EA027125B1 - Seed dressing for controlling phytopathogenic fungi of pyrenophora species - Google Patents

Abstract

The present invention relates to the use of Fluopyram for seed treatment, for corresponding seed dressings comprising Fluopyram, to a process for controlling phytopathogenic fungi by treating the seed with Fluopyram, and also to seed which has been treated with Fluopyram.

Description

The present invention relates to the use of fluopyram for seed treatment, for seed dressing with the corresponding fungicides and insecticides containing fluopyram, a method for controlling phytopathogenic fungi by treating seed with fluopyram, as well as seeds that have been treated with fluopyram.

Fluopyram is defined as a compound of formula (I)

Fluopyram is a broad-spectrum fungicide with penetrating and translaminar properties for use in foliar, drip, impregnation and seed treatment in a wide range of different crops from many economically important plant diseases. This is a very effective tool in preventive applications against species of powdery mildew, species of gray mold and white mold. It is effective against many other plant diseases. Fluopyram has been shown to be active in spore germination, germinal tube elongation and mycelium growth inhibition testing. At the biochemical level, fluopyram inhibits mitochondrial respiration by blocking electron transport in the respiratory chain of succinate dehydrogenase (complex II - 3ΌΗ inhibitor).

Fluopyram and its production process, starting with known and commercially available compounds, are described in EP-A-1389614 and AO 2004/016088.

The use of these compounds for seed treatment to protect against damage by phytopathogenic fungi transmitted with seeds has not yet been disclosed. In particular, the use of these compounds as a means for dressing seeds to protect against damage from Rugeporyoga §res1e§ is new.

It has now been discovered that fluopyram is very suitable for treating (etching) seeds against damage by phytopathogenic fungi.

It has been unexpectedly discovered that by using fluopyram in accordance with the invention as a seed dressing agent, some phytopathogenic fungi can be controlled much more effectively than by spraying in the case of foliar nutrition.

The active compounds in accordance with the invention have very good fungicidal properties and are especially suitable for controlling phytopathogenic fungi, for example yeast and deuteromycetes, when treating seeds. In the treatment of seeds, the active compounds according to the invention are particularly suitable for controlling Rugeporyoga §res1e§, which is transmitted with seeds.

Some pathogens that cause fungal diseases that fall under the generic names listed above can be mentioned as an example, but not as a limitation: transmitted with the seeds of Rugeporyoga §res1e§, such as, for example, R. auepae, R. dgashea, R.1egé§, R.Zesheshregba, R.1g1ys1-hereby8.

The fact that the active compounds that can be used are well tolerated by plants at the concentrations necessary to combat plant diseases allows seed treatment. Accordingly, the active compounds of the invention can be used as seed dressing agents.

Most of the damage to cultivated plants that are caused by phytopathogenic fungi occurs even when the seeds are affected during storage and after the seeds are introduced into the soil, during and immediately after plant emergence. This phase is especially important, since the roots and shoots of a growing plant are especially sensitive, and even slight damage can lead to the death of the entire plant. Therefore, the protection of seed and germinating plants through the use of suitable compositions is of particular interest.

The fight against phytopathogenic fungi, which damage plants after germination, is carried out, first of all, by cultivating the soil and aboveground parts of plants with plant protection products. Due to concerns about the possible effects of plant protection products on the environment and human and animal health, efforts are being made to reduce the amount of active compounds used.

The fight against phytopathogenic fungi by treating plant seeds has been known for a long time and is the subject of continuous improvements. However, seed treatment often entails a number of problems that cannot always be solved satisfactorily. Thus, it is desirable to develop methods for protecting seed and sprouting plants that do not require additional use of crop protection products after sowing or after plant emergence, or where additional applications are at least reduced. Moreover, quantity optimization is desirable.

- 1,027125 active compounds used in such a way as to provide maximum protection of the seed and germinating plant from damage by phytopathogenic fungi, but without damaging the plant itself with the active compound used. In particular, in seed treatment methods, the internal fungicidal properties of transgenic plants should also be taken into account in order to achieve optimal protection of the seed and germinating plants with the least amount of crop protection agents that are used.

Therefore, the presented invention, in particular, also relates to a method for controlling phytopathogenic fungi of Rugeioryoga dhashsha, which is transmitted with seeds, R.1gShc1-geryi8, transmitted with seeds and PTyeg, transmitted with seeds, by treating the inoculum with fluopyram.

In addition, the invention relates to seed that has been treated with fluopyram in order to provide protection against phytopathogenic fungi.

One of the advantages of the present invention is that the specific systemic properties of fluopyram suggest that treating the seeds with this compound not only protects the seed itself from phytopathogenic fungi, but also the seedlings obtained after germination. Thus, direct protection of crops at the time of sowing or soon after this may not be required.

In addition, it should be considered as an advantage that the invention can also be used, in particular, for transgenic seed.

The fluopyram according to the invention can be used to protect the seed of a plant variety that is used in agriculture, in a greenhouse, in forests or in horticulture. In particular, it is the seed of cereals (such as wheat, barley, rye, millet and oats), corn, cotton, soybeans, rice, potatoes, sunflowers, beans, coffee, beets (e.g. sugar beets and fodder beets) , peanuts, vegetables (such as tomatoes, cucumbers, onions and lettuce), lawn grass and ornamental plants. Processing seed of cereals (such as wheat, barley, rye and oats) is especially important.

In the context of the present invention, it can be applied to the seed, either alone or in a mixture with other compounds (fungicides, and / or insecticides, and / or biological control agents) in a suitable preparation. The composition in accordance with the invention, applied to the seed, may contain additional components, such as fertilizers, growth stimulants and / or inert carriers in a suitable composition. Preferably, the seed is treated in a condition that is stable enough to avoid damage during processing. In general, seed can be processed at any point in time between harvesting and sowing. The seed, commonly used, is separated from the plant and freed from the cobs, husks, stems, shells, awns or flesh of the fruit. Thus, for example, seed can be used that has been collected, cleaned and dried to a moisture content below 15 wt.%. Alternatively, you can also use seed that, after drying, for example, was treated with water and then dried again.

The following fungicides can be used in combination with a compound according to the formula (I) of fluopyram:

(1) Inhibitors of ergosterol biosynthesis, for example:

(1.1) aldimorph (1704-28-5), (1.2) azaconazole (60207-31-0), (1.3) bitertanol (55179-31-2), (1.4) bromukonazole (116255-48-2), (1.5 ) cyproconazole (113096-99-4), (1.6) dichlorobutrazole (75736-33-3), (1.7) diphenoconazole (119446-68-3), (1.8) diniconazole (83657-24-3), (1.9) diniconazole -M (83657-18-5), (1.10) dodemorph (1593-77-7), (1.11) dodemorph acetate (31717-87-0), (1.12) epoxyconazole (106325-08-0), (1.13) ethaconazole (60207-93-4), (1.14) phenarimol (60168-88-9), (1.15) fenbuconazole (114369-43-6), (1.16) fenhexamide (126833-17-8), (1.17) phenpropidine ( 67306-00-7), (1.18) fenpropimorph (67306-03-0), (1.19) flukhinconazole (136426-54-5), (1.20) flurprimidol (56425-91-3), (1.21) flusilazole (85509- 19-9), (1.22) flutriafol (76674-21-0),

- 2 027125 (1.23) furconazole (112839-33-5), (1.24) furconazole-cis (112839-32-4), (1.25) hexaconazole (79983-71-4), (1.26) imazalil (60534-80- 7), (1.27) imazalil sulfate (58594-72-2), (1.28) imibenconazole (86598-92-7), (1.29) ipconazole (125225-28-7), (1.30) metconazole (125116-23-6 ), (1.31) miklobutanyl (88671-89-0), (1.32) naphthyne (65472-88-0), (1.33) nuarimol (63284-71-9), (1.34) oxpoconazole (174212-12-5), (1.35) paclobutrazole (76738-62-0), (1.36) pefurazoate (101903-30-4), (1.37) penconazole (66246-88-6), (1.38) piperaline (3478-94-2), (1.39 ) prochlorase (67747-09-5), (1.40) propiconazole (60207-90-1), (1.41) prothioconazole (178928-70-6), (1.42) pyributicarb (88678-67-5), (1.43) pyrifenox (88283-41-4), (1.44) hinconazole (103970-75-8), (1.45) simek nazol (149508-90-7), (1.46) spiroxamine (118134-30-8), (1.47) tebuconazole (107534-96-3), (1.48) terbinafine (91161-71-6), (1.49) tetraconazole ( 112281-77-3), (1.50) triadimephone (43121-43-3), (1.51) triadimenol (89482-17-7), (1.52) tridemorph (81412-43-3), (1.53) triflumisole (68694- 11-1), (1.54) triforin (26644-46-2), (1.55) triticonazole (131983-72-7), (1.56) uniconazole (83657-22-1), (1.57) uniconazole-p (83657- 17-4), (1.58) viconazole (77174-66-4), (1.59) voriconazole (137234-62-9), (1.60) 1- (4-chlorophenyl) -2- (1H-1,2,4 -triazol-1-yl) cycloheptanol (129586-32-9), (1.61) methyl 1- (2,2-dimethyl-2,3-dihydro-1H-inden-1-yl) -1H-imidazol-5- carboxylate (110323-95-0), (1.62) No.- {5- (difluoromethyl) -2-methyl-4- [3- (trimethylsilyl) propoxy] phen l} -M-ethyl-Nmethylimidoformamide, (1.63) I-ethyl-H-methyl-No.- {2-methyl-5- (trifluoromethyl) -4- [3- (trimethylsilyl) propoxy] phenyl} imidoformamide and (1.64) O- [1- (4-methoxyphenoxy) -3,3-dimethylbutan-2-yl] -1H-imidazole-1-carbothioate (111226-71-2).

(2) Respiratory chain inhibitors in complex I or II, for example:

(2.1) bixafen (581809-46-3), (2.2) boscalide (188425-85-6), (2.3) carboxin (5234-68-4), (2.4) diflumetor (130339-07-0), (2.5 ) fenfuram (24691-80-3), (2.7) flutolanil (66332-96-5), (2.8) fluxapyroxad (907204-31-3), (2.9) furametrip (123572-88-3), (2.10) furmecyclox (60568-05-0), (2.11) isopirazam (a mixture of 1Κδ, 4δΚ, 9Κδ syn-epimeric racemate and 1K5.48K, 98K antiepimeric racemate) (881685-58-1), (2.12) isopirazam (1K8 antiepimeric racemate, 48K, 98K), (2.13) isopyrazam (antiepimeric enantiomer 1K, 48.98), (2.14) isopyrazam (antiepimeric enantiomer 18.4K9K).

(2.15) isopyrazam (syn-epimeric racemate 1K8.48K, 9K8), (2.16) isopyrazam (syn-epimeric enantiomer 1K, 48.9K), (2.17) isopyrazam (syn-epimeric enantiomer 18.4K, 98),

- 3 027125 (2.18) mepronil (55814-41-0), (2.19) oxycarboxin (5259-88-1), (2.20) penflufen (494793-67-8), (2.21) pentiopyrad (183675-82-3) , (2.22) sedaxane (874967-67-6), (2.23) tiflusamide (130,000-40-7), (2.24) 1-methyl-L- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -3- (trifluoromethyl) -1H-pyrazole-4-carboxamide, (2.25) 3- (difluoromethyl) -1-methyl-Y- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazole -4-carboxamide, (2.26) 3- (difluoromethyl) -Y- [4-fluoro-2- (1,1,2,3,3,3-hexafluoropropoxy) phenyl] -1-methyl-1H-pyrazole-4-carboxamide , (2.27) N- [1 - (2,4-dichlorophenyl) -1-methoxypropan-2-yl] -3 - (difluoromethyl) -1-methyl-1H-pyrazole-4carboxamide (1092400-95-7) (No. O 2008/148570), (2.28) 5.8-difluoro ^ - [2- (2-fluoro-4 - {[4- (trifluoromethy l) pyridin-2-yl] oxy} phenyl) ethyl] quinazolin-4amine (1210070-84-0) (No. O 201/0025451), (2.29) U [9- (dichloromethylene) -1,2,3,4 -tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoromethyl) -1methyl-1H-pyrazole-4-caboxamide, (2.30) U [(18.4K) -9- (dichloromethylene) -1.2 , 3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3 (difluoromethyl) -1-methyl-1H-pyrazol-4-caboxamide and (2.31) Y [(1K, 48) -9- (dichloromethylene ) -1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3 (difluoromethyl) -1-methyl-1H-pyrazol-4-caboxamide, Yu [9- (dichloromethylene) -1, 2,3,4-tetrahydro-1,4-methanonaphthalene-5-yl] -3 - (difluoromethyl) -1-methyl-1H-pyrazole-4-caboxamide.

(3) Inhibitors of the respiratory chain in complex III, for example:

(3.1) ametoctradine (865318-97-4), (3.2) amisulbrom (348635-87-0), (3.3) azoxystrobin (131860-33-8), (3.4) cyazofamide (120168-88-3), (3.5 ) caumethoxystrobin (850881-30-0), (3.6) caumoxystrobin (850881-70-8), (3.7) dimoxystrobin (141600-52-4), (3.8) enestroburin (238410-11-2) (No. O 2004 / 058723), (3.9) famoxadone (131807-57-3) (No. O 2004/058723), (3.10) phenamidone (161326-34-7) (No. O 2004/058723), (3.11) phenoxystrobin (918162-02- 4), (3.12) fluoxastrobin (361377-29-9) (No. O 2004/058723), (3.13) kresoximethyl (143390-89-0) (No. O 2004/058723), (3.14) methominostrobin (133408-50- 1) (No. O 2004/058723), (3.15) orisastrobin (189892-69-1) (No. O 2004/058723), (3.16) picoxystrobin (117428-22-5) (No. O 2004/058723), (3.17 ) pyraclostrobin (175013-18-0) (No. O 2004/058723), (3.18) pyramethostrobin (915410-70-7) (No. O 2004/058723), (3.19) pyraoxystrobin (862588-11-2) (No. O 2004/058723), (3.20) pyribencarb (799247-52-2) ( No. O 2004/058723), (3.21) triclopiricarb (902760-40-1), (3.22) trifloxystrobin (141517-21-7) (No. O 2004/058723), (3.23) (2E) -2- (2- {[6- (3-chloro-2-methylphenoxy) -5-fluoropyrimidin-4-yl] oxy} phenyl) -2 (methoxyimino) -Mumethylethanamide (\ UO 2004/058723), (3.24) (2E) -2- (methoxyimino) ^ - methyl-2- (2 - {[({(1E) -1- [3- (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) ethanamide (\ UO 2004/058723), ( 3.25) (2E) -2- (methoxyimino) ^ - methyl-2- {2 - [(E) - ({1- [3- (trifluoromethyl) phenyl] ethoxy} imino) methyl] phenyl} ethanamide (158169-73 -4), (3.26) (2E) -2- {2 - [({[((1E) -1- (3 - {[(E) -1-fluoro-2-phenylete nyl] oxy} phenyl) ethylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) ^ - methylethanamide (326896-28-0), (3.27) (2E) -2- {2 - [({[( 2E, 3E) -4- (2,6-dichlorophenyl) but-3-en-2-ylidene] amino} oxy) methyl] phenyl} -2 (methoxyimino) -Umethylethanamide, (3.28) 2-chloro-Yu (1 , 1,3-trimethyl-2,3-dihydro-1H-inden-4-yl) pyridin-3-carboxamide (119899-14-8), (3.29) 5-methoxy-2-methyl-4- (2- {[({((1E) -1- [3- (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) -2,4-dihydro-3H-1,2,4-triazol-3-one, ( 3.30) methyl (2E) -2- {2 - [({cyclopropyl [(4-methoxyphenyl) imino] methyl} sulfanyl) methyl] phenyl} -3 methoxyprop-2-enoate (149601-03-6), (3.31) U (3-ethyl-3,5,5-trimethylcyclohexyl) -3- (formylamino) -2-guide oxybenzamide (226551-21-9), (3.32) 2- {2 - [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-Yumethylacetamide (173662-97-0) and (3.33) (2K) - 2- {2 - [(2,5-dimethylphenoxy) methyl] phenyl} -2-methoxy-yumethylacetamide (394657-24-0).

- 4 027125 (4) Inhibitors of mitosis and cell division, for example:

(4.1) benomyl (17804-35-2), (4.2) carbendazim (10605-21-7), (4.3) chlorphenazole (3574-96-7), (4.4) diethofencarb (87130-20-9), (4.5 ) etaboxam (162650-77-3), (4.6) fluopicolide (239110-15-7), (4.7) fuberidazole (3878-19-1), (4.8) pencicuron (66063-05-6), (4.9) thiabendazole (148-79-8), (4.10) thiophanate methyl (23564-05-8), (4.11) thiophanate (23564-06-9), (4.12) zoxamide (156052-68-5), (4.13) 5-chlorine -7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluorophenyl) [1,2,4] triazolo [1,5-a] pyrimidine (214706-53-3) and (4.14 ) 3-chloro-5- (6-chloropyridin-3-yl) -6-methyl-4- (2,4,6-trifluorophenyl) pyridazine (1002756-87-7).

(5) Compounds capable of multidirectional actions, such as, for example:

(5.1) Bordeaux liquid (8011-63-0), (5.2) captafol (2425-06-1), (5.3) captan (133-06-2) (No. O 02/12172), (5.4) chlorothalonil (1897 -45-6), (5.5) copper hydroxide (20427-59-2), (5.6) copper naphthenate (1338-02-9), (5.7) copper oxide (1317-39-1), (5.8) copper oxychloride (1332-40-7), (5.9) copper sulfate (2+) (7758-98-7), (5.10) dichlorofluanide (1085-98-9), (5.11) dithianone (3347-22-6), ( 5.12) dodin (2439-10-3), (5.13) free base of dodin, (5.14) ferbam (14484-64-1), (5.15) fluorofolpet (719-96-0), (5.16) folpet (133-07 -3), (5.17) guazatin (108173-90-6), (5.18) guazatin acetate, (5.19) iminoctadine (13516-27-3), (5.20) iminoctadine albesilate (169202-06-6), (5.21) iminoctadine triacetate (57520-17-9), (5.22) mancopper (53988-93-5), (5.23) ma koseb (8018-01-7), (5.24) maneb (12427-38-2), (5.25) metira (9006-42-2), (5.26) metira zinc (9006-42-2), (5.27) oxine copper (10380-28-6), (5.28) propamidine (104-32-5), (5.29) propineb (12071-83-9), (5.30) sulfur and sulfur preparations, including calcium polysulfide (7704-34-9 ), (5.31) thiram (137-26-8), (5.32) tolylfluanide (731-27-1), (5.33) zineb (12122-67-7) and (5.34) ziram (137-30-4).

(6) Compounds capable of inducing immune defense, for example:

(6.1) acibenzolar-8-methyl (135158-54-2), (6.2) isothianyl (224049-04-1), (6.3) probenazole (27605-76-1) and (6.4) thiadinyl (223580-51-6 )

(7) Inhibitors of the biosynthesis of amino acids and / or protein, for example:

(7.1) andoprim (23951-85-1), (7.2) blasticidin-8 (2079-00-7), (7.3) cyprodinil (121552-61-2), (7.4) casugamycin (6980-18-3), (7.5) casugamycin hydrochloride hydrate (19408-46-9), (7.6) mepanipyrim (110235-47-7), (7.7) pyrimethanil (53112-28-0) and

5 027125 (7.8) 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline (No. 0 2005/070917).

(8) ATP production inhibitors, for example:

(8.1) fentin acetate (900-95-8), (8.2) fentin chloride (639-58-7), (8.3) fentin hydroxide (76-87-9) and (8.4) silthiofam (175217-20-6).

(9) Inhibitors of cell wall synthesis, for example:

(9.1) bentiavalicarb (177406-68-7), (9.2) dimethomorph (110488-70-5), (9.3) flumorph (211867-47-9), (9.4) iprovalicarb (140923-17-7), (9.5 ) mandipropamide (374726-62-2), (9.6) polyoxins (11113-80-7), (9.7) polyoxorim (22976-86-9), (9.8) validamycin (37248-47-8) and (9.9) valifenalate (283159-94-4; 283159-90-0).

(10) Inhibitors of lipid and membrane synthesis, for example:

(10.1) biphenyl (92-52-4), (10.2) chlorneb (2675-77-6), (10.3) dicloran (99-30-9), (10.4) edifenfos (17109-49-8), (10.5 ) ethridiazole (2593-15-9), (10.6) iodocarb (55406-53-6), (10.7) iprobenfos (26087-47-8), (10.8) isoprothiolane (50512-35-1), (10.9) propamocarb (25606-41-1), (10.10) propamocarb hydrochloride (25606-41-1), (10.11) prothiocarb (19622-08-3), (10.12) pyrazophos (13457-18-6), (10.13) quintozene ( 82-68-8), (10.14) teknazen (117-18-0) and (10.15) tolclofos-methyl (57018-04-9).

(11) Inhibitors of melanin biosynthesis, for example:

(11.1) Carpropamide (104030-54-8), (11.2) Diclocimet (139920-32-4), (11.3) Phenoxanyl (115852-48-7), (11.4) Phthalide (27355-22-2), (11.5 ) pyrochilone (57369-32-1), (11.6) tricyclazole (41814-78-2) and (11.7) 2,2,2-trifluoroethyl {3-methyl-1 - [(4-methylbenzoyl) amino] butan-2 -yl} carbamate (No. 0 2005/042474).

(12) Nucleic acid synthesis inhibitors, for example:

(12.1) benalaxyl (71626-11-4), (12.2) benalaxyl-M (chiralaxyl) (98243-83-5), (12.3) bupirimat (41483-43-6), (12.4) closilacon (67932-85- 8), (12.5) dimethyrimol (5221-53-4), (12.6) ethyrimol (23947-60-6), (12.7) furalaxyl (57646-30-7), (12.8) gimexazole (10004-44-1) , (12.9) metalaxyl (57837-19-1), (12.10) metalaxyl-M (mefenoxam) (70630-17-0), (12.11) ofuras (58810-48-3), (12.12) oxadixyl (77732-09 -3) and (12.13) oxolinic acid (14698-29-4).

(13) Signal transduction inhibitors, for example:

(13.1) chlozolinate (84332-86-5), (13.2) fenpiclonil (74738-17-3), (13.3) fludioxonil (131341-86-1), (13.4) iprodione (36734-19-7), (13.5 ) procymidone (32809-16-8), (861647-32-7) (851524-22-6)

- 6,027,125 (13.6) quinoxifene (124495-18-7) and (13.7) vinclozolin (50471-44-8).

(14) Compounds capable of acting as uncoupling agents, for example:

(14.1) binapacryl (485-31-4), (14.2) dinocap (131-72-6), (14.3) ferimzone (89269-64-7), (14.4) fluazines (79622-59-6) and (14.5 ) meptyldinocap (131-72-6).

(15) Additional compounds, for example:

(15.1) bentiazole (21564-17-0), (15.2) betoxazine (163269-30-5), (15.3) capsimycin (70694-08-5), (15.4) carvone (99-49-0), (15.5 ) quinomethionate (2439-01-2), (15.6) pyriophenone (chlazaphenone) (688046-61-9), (15.7) kufraneb (11096-18-7), (15.8) cyflufenamide (180409-60-3), ( 15.9) cymoxanil (57966-95-7), (15.10) cyprosulfamide (221667-31-8), (15.11) dazomet (533-74-4), (15.12) debacarb (62732-91-6), (15.13) dichlorophene (97-23-4), (15.14) diclomesine (62865-36-5), (15.15) diphenzocvate (49866-87-7), (15.16) diphenzocvate methyl sulfate (43222-48-6), (15.17) diphenylamine (122-39-4), (15.18) ecomat, (15.19) fenpirazamine (473798-59-3), (15.20) flumetover (154025-04-4), (15.21) fluorimide (41205-21-4), ( 15.22) flusulfamide (106917-52-6), (15.23) flutianil (304900-25- 2), (15.24) aluminum fosetyl (39148-24-8), (15.25) calcium fosetyl, (15.26) sodium fosetyl (39148-16-8), (15.27) hexachlorobenzene (118-74-1), (15.28) irumamycin (81604-73-1), (15.29) metasulfocarb (66952-49-6), (15.30) methyl isothiocyanate (556-61-6), (15.31) metraphenone (220899-03-6), (15.32) mildiomycin ( 67527-71-3), (15.33) natamycin (7681-93-8), (15.34) nickel dimethyldithiocarbamate (15521-65-0), (15.35) nitrothalisopropyl (10552-74-6), (15.36) octilinone (26530 -20-1), (15.37) oxamocarb (917242-12-7), (15.38) oxyfentiin (34407-87-9), (15.39) pentachlorophenol and its salts (87-86-5), (15.40) phenotrin, (15.41) phosphorous acid and its salts (13598-36-2), (15.42) propamocarb fosetylate, (15.43) sodium propanosine (88498-02-6), (15.44) proquinazide (189278-12-4), (15.45) pyrimorph (868390-90-3), (15.45е) (2Е) -3 - (4-tert-butylphenyl) - 3 - (2-chloropyridin-4-yl) -1 - (morpholin-4-yl) prop-2-en-1-one (1231776-28-5), (15.45ζ) (2Ζ) -3 - (4 tert-butylphenyl) -3 - (2-chloropyridin-4-yl) -1 - (morpholin-4-yl) prop-2-en-1-one (1231776-29-6), (15.46) pyrrolnitrin (1018 -71-9) (EP-A 559 320 1), (15.47) tebufloquin (376645-78-2), (15.48) teclofthalam (76280-91-6), (15.49) tolnifanide (304911-98-6),

- 7 027125 (15.50) triazoxide (72459-58-6), (15.51) trichlamide (70193-21-4), (15.52) sarylamide (84527-51-5), (15.53) (3§, 6§, 7К , 8K) -8-benzyl-3 - [({3 - [(isobutyryloxy) methoxy] -4-methoxypyridin-2yl} carbonyl) amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7 -yl 2-methylpropanoate (517875-34-2) (No. O 2003/035617), (15.54) 1- (4- {4 - [(5K) -5- (2,6-difluorophenyl) -4,5- dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] ethanone (1003319-79-6) (No. O 2008/013622), (15.55) 1- (4- {4 - [(5§) -5- (2,6-difluorophenyl) -4,5-dihydro-1, 2-oxazol-3-yl] -1,3-thiazol-2yl} piperidin-1-yl) -2- [5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] ethanone (1003319-80 -9) (No. O 2008/013622), (15.56) 1- (4- {4- [5- (2,6-difluoro) enyl) -4,5-dihydro-1,2-oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1yl) -2- [5-methyl-3- (trifluoromethyl) -1H- pyrazol-1-yl] ethanone (1003318-67-9) (\ UO 2008/013622), (15.57) 1- (4-methoxyphenoxy) -3,3-dimethylbutan-2-yl 1H-imidazole-1-carboxylate ( 111227-17-9), (15.58) 2,3,5,6-tetrachloro-4- (methylsulfonyl) pyridine (13108-52-6), (15.59) 2,3-dibutyl-6-chlorothieno [2,3 -O] pyrimidin-4 (3H) -one (221451-58-7), (15.60) 2,6-dimethyl-1H, 5H- [1,4] dithiino [2,3-s: 5,6-s '] dipyrrole-1,3,5,7- (2H, 6H) tetron, (15.61) 2- [5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] -1- (4- { 4 - [(5K) -5-phenyl-4,5-dihydro-1,2oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone (1003316-53-7) (\ UO 2008/013622), (15.62) 2- [5-methyl-3- (trifluoromethyl) -1H-pi azol-1-yl] -1- (4- {4 - [(5§) -5-phenyl-4,5-dihydro-1,2oxazol-3-yl] -1,3-thiazol-2-yl} piperidin-1-yl) ethanone (1003316-54-8) (\ UO 2008/013622), (15.63) 2- [5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] -1- { 4- [4- (5-phenyl-4,5-dihydro-1,2-oxazol-3yl) -1,3-thiazol-2-yl] piperidin-1-yl} ethanone (1003316-51-5) ( \ UO 2008/013622), (15.64) 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, (15.65) 2-chloro-5- [2-chloro-1- (2.6 -difluoro-4-methoxyphenyl) -4-methyl-1H-imidazol-5-yl] pyridine, (15.66) 2-phenylphenol and salts (90-43-7), (15.67) 3- (4,4,5- trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline (861647-85-0) (No. O 2005/070917), (15.68) 3,4,5-trichloropyridin-2,6-dicarbonitrile (17824-85-0), (15.69) 3- [5- (4-chlorophenyl) -2,3-dimethyl-1,2- oxazolidin-3-yl] pyridine, (15.70) 3-chloro-5- (4-chlorophenyl) -4- (2,6-difluorophenyl) -6-methylpyridazine (15.71) 4- (4-chlorophenyl) -5 (2,6-difluoro phenyl) -3,6-dimethylpyridazine, (15.72) 5-amino-1,3,4-thiadiazole-2-thiol (15.73) 5-chloro-No.-phenyl-No.- (prop -2-yn-1-yl) thiophen-2sulfonohydrazine (134-31-6), (15.74) 5-fluoro-2 - [(4-fluorobenzyl) oxy] pyrimidin-4-amine (1174376-11-4) ( \ UO 2009/094442), (15.75) 5-fluoro-2 - [(4-methylbenzyl) oxy] pyrimidin-4-amine (1174376-25-0) (\ UO 2009/094442), (15.76) 5-methyl -6-octyl [1,2,4] triazolo [1,5-a] pyrimidin-7-amine, (15.77) ethyl (22) -3-amino-2-cyano-3-phenylprop-2-enoic acid, (15.78) No.- (4 - {[3- (4-chlorobenzyl) -1,2,4-thiadiazol-5-yl] oxy} -2,5-dimethylphenyl) - ^ ethyl ^ methylimidoformamide, (15.79) N- (4-chlorobenzyl) -3 - [3-methoxy-4- (prop-2-in-1-yloxy) phenyl] propanamide, (15.80) M - [(4-chlorophenyl) (cyano ) methyl] -3- [3-methoxy-4- (prop-2-yn-1-yloxy) phenyl] propanamide, (15.81) N - [(5-bromo-3-chloropyridin-2-yl) methyl] - 2,4-Dichloropyridin-3-carboxamide (15.82) N- [1 - (5-bromo-3-chloropyridin-2-yl) ethyl] -2,4-dichloropyridin-3-carboxamide, (15.83) N- [1 - (5-bromo-3-chloropyridin-2-yl) ethyl] -2-fluoro-4-iodopyridin-3-carboxamide, (15.84) Ν- {(K) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy ) -2,3-difluorophenyl] methyl} -2 phenylacetamide (221201-92-9), (15.85) ^ {(2) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluorophore yl] methyl} -2 phenylacetamide (221201-92-9), (15.86) No.- {4 - [(3-tert-butyl-4-cyano-1,2-thiazol-5-yl) oxy] -2-chloro -5-methylphenyl} - ^ ethyl ^ methylimidoformamide, (15.87) ^ methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] acetyl} piperidin-4-yl) (1,2,3,4-tetrahydronaphthalen-1-yl) -1,3-thiazole-4-caboxamide (922514-49-6) (\ UO 2007/014290), (15.88) ^ methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) -1H-pyrazol-1-yl] acetyl} piperidin-4-yl) [(1K) -1,2,3,4-tetrahydronaphthalen-1-yl] -1 , 3-thiazole-4-caboxamide (922514-07-6) (\ UO 2007/014290), (15.89) ^ methyl-2- (1 - {[5-methyl-3- (trifluoromethyl) -1H-pyrazole- 1-yl] acetyl} piperidin-4-yl) [(18) -1,2,3,4-tetrahydronaphthalen-1-yl] -1,3-thiazole-4-caboxamide (9 22514-48-5) (\ UO 2007/014290), (15.90) pentyl {6 - [({[(1-methyl-1H-tetrazol-5-yl) (phenyl) methylidene] amino} oxy) methyl] pyridine -2yl} carbamate, (15.91) phenazin-1-carboxylic acid, (15.92) quinolin-8-ol (134-31-6),

- 8 027125 (15.93) quinolin-8-ol sulfate (2: 1) (134-31-6) and (15.94) tert-butyl {6 - [({[((1-methyl-1H-tetrazol-5-yl) ) (phenyl) methylene] amino} hydroxy) methyl] pyridin-2yl} carbamate.

(16) Additional compounds, for example:

(16.1) 1-methyl-3- (trifluoromethyl) -Y- [2 '- (trifluoromethyl) biphenyl-2-yl] -1H-pyrazole-4-carboxamide, (16.2) Y- (4'-chlorobiphenyl-2- il) -3- (difluoromethyl) -1-methyl-1H-pyrazole-4-carboxamide, (16.3) N- (2 ', 4'-dichlorobiphenyl-2-yl) -3- (difluoromethyl) -1-methyl- 1H-pyrazole-4-carboxamide, (16.4) 3- (difluoromethyl) -1-methyl-Y- [4 '- (trifluoromethyl) biphenyl-2-yl] -1H-pyrazole-4-carboxamide, (16.5) Н- (2 ', 5'-difluorobiphenyl-2-yl) -1-methyl-3- (trifluoromethyl) -1H-pyrazole-4-carboxamide, (16.6) 3- (difluoromethyl) -1-methyl-Y- [4' - (prop-1-yn-1-yl) biphenyl-2-yl] -1H-pyrazole-4-carboxamide (known from AO 2004/058723), (16.7) 5-fluoro-1,3-dimethyl-Y- [4 '- (prop-1-yn-1-yl) biphenyl-2-yl] -1H-pyrazo l-4-carboxamide (known from AO 2004/058723), (16.8) 2-chloro-Y- [4 '- (prop-1-yn-1-yl) biphenyl-2-yl] pyridin-3-carboxamide ( known from AO 2004/058723), (16.9) 3- (difluoromethyl) -Y- [4 '- (3,3-dimethylbut-1-yn-1-yl) biphenyl-2-yl] -1-methyl-1H pyrazole-4-carboxamide (known from AO 2004/058723), (16.10) Y- [4 '- (3,3-dimethylbut-1-yn-1-yl) biphenyl-2-yl] -5-fluoro-1, 3-dimethyl-1H-pyrazole-4carboxamide (known from AO 2004/058723), (16.11) 3- (difluoromethyl) -Y- (4'-ethynylbiphenyl-2-yl) -1-methyl-1H-pyrazol-4- carboxamide (known from AO 2004/058723), (16.12) L - [- (4'-ethynylbiphenyl-2-yl) -5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide (known from AO 2004 / 058723), (16.13) 2-chloro-Y- (4 '-ethynylbiphenyl-2-yl) pyridin-3-carboxamide (known from AO 2004/058723), (16.14) 2-chloro-Y- [4' - (3,3-dimethylbut-1-yn-1-yl) biphenyl-2-yl] pyridin-3-carboxamide (known from AO 2004/058723), (16.15) 4- (difluoromethyl) -2-methyl-Y- [4 '- (trifluoromethyl) biphenyl-2-yl] -1 , 3-thiazole-5-carboxamide (known from AO 2004/058723), (16.16) 5-fluoro-Y- [4 '- (3-hydroxy-3-methylbut-1-in-1-yl) biphenyl-2 -yl] -1,3-dimethyl-1H-pyrazole-4carboxamide (known from AO 2004/058723), (16.17) 2-chloro-Y- [4 '- (3-hydroxy-3-methylbut-1-yn- 1-yl) biphenyl-2-yl] pyridin-3-carboxamide (known from AO 2004/058723), (16.18) 3- (difluoromethyl) -Y- [4 '- (3-methoxy-3-methylbut-1- yn-1-yl) biphenyl-2-yl] -1-meth l-1 Npyrazol-4-caboxamide (known from AO 2004/058723), (16.19) 5-fluoro-Y- [4 '- (3-methoxy-3-methylbut-1-in-1-yl) biphenyl-2- yl] -1,3-dimethyl-1H-pyrazole-4carboxamide (known from AO 2004/058723), (16.20) 2-chloro-I- [4 '- (3-methoxy-3-methylbut-1-in-1 -yl) biphenyl-2-yl] pyridin-3-carboxamide (known from AO 2004/058723), (16.21) (5-bromo-2-methoxy-4-methylpyridin-3-yl) (2,3,4- trimethoxyphenyl-6-methylphenyl) methanone (known from EP-A-1559320), (16.22) Y- [2- (4 - {[3- (4-chlorophenyl) prop-2-yn-1-yl] oxy} - 3-methoxyphenyl) ethyl] -M2 (methylsulfonyl) valinamide (220706-93-4), (16.23) 4-oxo-4 - [(2-phenylethyl) amino] butanoic acid and (16.24) but-3-in-1 -yl- {6 - [({[(2) - (1-methyl-1H-te trazol-5-yl) (phenyl) methylene] amino} oxy) methyl] pyridin-2-yl} carbamate.

All of these mixing components of classes (1) to (16) may, if their functional groups permit, include, optionally, salts with suitable bases or acids.

In a preferred embodiment, the fungicides used in combination with the compound according to formula (I) of fluopyram are selected from the following list:

azoxystrobin, boscalide, penflufen (Y- [2- (1,3-dimethylbutyl) phenyl] -5-fluoro-1,3-dimethyl-1-pyrazole-4-carboxamide), carbendazim, fludioxonil, fluopicolide, fluxapirade, fluoxastrobin, fluoxastrobin, fluxastrobin, fluxastrobin, fluxastrobin, fluxastrobin, ipconazole, isopyrazam, isothianyl, metalaxyl, pencicuron, pentiopyrad, prochlorase, prothioconazole, pyraclostrobin, pyrimethanil, sedaxane, tebuconazole, triadimenol, trifloxystrobin, triticonazole, M- [9- (tetra-1,2-dichloro-1,2-dichloromethane , 4-methanonaphthalen-5-yl] -3- (difluoromethyl) -1methyl-1H-pyrazole-4-caboxamide, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid [2- (2,4- di lorfenil) -2-methoxy-1-methylethyl] amide.

In a preferred embodiment, the fungicides used in combination with the compound according to formula (I) of fluopyram are selected from the following list:

azoxystrobin, boscalide, penflufen (Y- [2- (1,3-dimethylbutyl) phenyl] -5-fluoro-1,3-dimethyl-1-pyrazole-4-carboxamide), carbendazim, fludioxonil, fluopicolide, fluxapirade, fluoxastrobin, fluoxastrobin, fluxastrobin, fluxastrobin, fluxastrobin, fluxastrobin, fluxastrobin, ipconazole, isopyrazam, isothianyl, metalaxyl, pencicuron, pentiopyrad, prochlorase, prothioconazole, pyraclostrobin, pyrimethanil, sedaxane, tebuconazole, triadimenol, trifloxystrobin,

- 9 027125 triticonazole, M- [9- (dichloromethylene) -1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl] -3- (difluoromethyl) -1methyl-1H-pyrazole-4-caboxamide , 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid [2- (2,4-dichlorophenyl) -2-methoxy-1-methylethyl] amide.

The following insecticides can be used in combination with the compound according to formula (I) fluopyram.

The active ingredients indicated in this document under their common name are known and described, for example, in the Pesticide Guide (TNe RsShsShs Mapia1, 14 * Εά., SPShR Sgor RgOyusOop SoipsP, 2006) or can be found on the Internet (for example, 1Sp: //\у\у\u.a1ap\uoo6.pe1/re50s1be5).

(1) Acetylcholinesterase (ACHE) inhibitors, e.g. carbamates, e.g. alanicarb (ΙΙ-1-1), aldicarb (ΙΙ-1-2), bendiocarb (ΙΙ-1-3), benfuracarb (ΙΙ-1-4), butocarboxim (ΙΙ-1-5), butoxycarboxy (ΙΙ-1-6), carbaryl (ΙΙ-1-7), carbofuran (ΙΙ-1-8), carbosulfan (ΙΙ-1-9), etiofencarb (ΙΙ-1- 10), phenobucarb (ΙΙ-1-11), formethanate (ΙΙ-1-12), furatiocarb (ΙΙ-1-13), isoprocarb (ΙΙ-1-14), methiocarb (ΙΙ-1-15), metomil ( ΙΙ-1-16), metolcarb (ΙΙ-1-17), oxamyl (ΙΙ-1-18), pyrimicarb (ΙΙ-1-19), propoxur (ΙΙ-1-20), thiodicarb (ΙΙ-1-21 ), thiofanox (ΙΙ-1-22), triazamate (ΙΙ-1-23), trimethacarb (ΙΙ-1-24), HMS (ΙΙ-1-25) and xylylcarb (ΙΙ-1-26); or organophosphorus compounds, for example, acephate (ΙΙ-1-27), azamethiphos (ΙΙ-1-28), azinphosethyl (ΙΙ-1-29), azinphos-methyl (ΙΙ-1-30), cadusafos (ΙΙ-1-31 ), chloroethoxyphos (ΙΙ-1-32), chlorphenvinphos (ΙΙ-1-33), chlormefos (ΙΙ-1-34), chlorpyrifos (ΙΙ-1-35), chlorpyrifos-methyl (ΙΙ-1-36), coumaphos (ΙΙ-1-37), cyanophos (ΙΙ-1-38), demethone-8-methyl- (P-1-39), diazinon (ΙΙ-1-40), dichlorophos / IIUR (ΙΙ-1-41) , dicrotophos (ΙΙ-1-42), dimethoate (ΙΙ-1-43), dimethylvinphos (ΙΙ-1-44), disulfotone (ΙΙ-1-45), ΕΡΝ (ΙΙ-1-46), ethion (ΙΙ- 1-47), etoprofos (ΙΙ-1-48), famfur (ΙΙ-1-49), phenamiphos (ΙΙ-1-50), phenytrotion (ΙΙ-1-51), fenthion (ΙΙ-1-52), fostiazate (ΙΙ-1-53), hepato wasp (ΙΙ-1-54), imitsiaphos (ΙΙ-1-55), isofenphos (ΙΙ-1-56), isopropyl O- (methoxyaminothiophosphoryl) salicylate (ΙΙ-1-57), isoxathion (ΙΙ-1-58) , malathion (ΙΙ-1-59), mekarbam (ΙΙ-1-60), metamidophos (ΙΙ-1-61), methidation (ΙΙ-1-62), mevinphos (ΙΙ-1-63), monocrotophos (ΙΙ- 1-64), ice (ΙΙ-1-65), methoate (ΙΙ-1-66), oxydemeton-methyl (ΙΙ-1-67), parathion (ΙΙ-1-68), parathion-methyl (ΙΙ-1 -69), fentoate (ΙΙ-1-70), forat (ΙΙ-1-71), fosalon (ΙΙ-1-72), phosphate (ΙΙ-1-73), phosphamidone (ΙΙ-1-74), foxim (ΙΙ-1-75), pyrimifosmethyl (ΙΙ-1-76), profenofos (ΙΙ-1-77), propetamphos (ΙΙ-1-78), prothiophos (ΙΙ-1-79), pyraclophos (ΙΙ-1- 80), pyridafenthion (ΙΙ-1-81), quinalphos (Ι -1-82), sulfotep (ΙΙ-1-83), tebupirimphos (ΙΙ-1-84), temefos (ΙΙ-1-85), terbufos (ΙΙ-1-86), tetrachlorvinphos (ΙΙ-1-87) , thiometon (ΙΙ-1-88), triazophos (ΙΙ-1-89), trichlorfon (ΙΙ-1-90) and vamidothion (ΙΙ-1-91).

(2) Antagonists of GABA-driven chloride channels, for example organochloride compounds, for example, chlordane (ΙΙ-2-1) and endosulfan (ΙΙ-2-2); or phenylpyrazoles (fiprols), for example, etiprol (ΙΙ-2-3) and fipronil (ΙΙ-2-4).

(3) Sodium channel modulators / voltage-gated sodium channel blockers, e.g. pyrethroids, e.g. acrinatrin (ΙΙ-3-1), allethrin (ΙΙ-3-2), Ό-cis-trans-allethrin (ΙΙ-3-3), Ό -transalletrin (ΙΙ-3-4), bifentrin (ΙΙ-3-5), bioalletrin (ΙΙ-3-6), bioallertrin δ-cyclopentenyl isomer (ΙΙ-3-7), bioresmetrin (ΙΙ-3-8), cycloprotrin (ΙΙ-3-9), cyfluthrin (ΙΙ-3-10), beta-cyfluthrin (ΙΙ-3-11), cygalotrin (ΙΙ-3-12), lambda-cygalotrin (ΙΙ-3-13), gamma -cygalotrin (ΙΙ-3-14), cypermethrin (ΙΙ-3-15), alpha-cypermethrin (ΙΙ-3-16), beta-cypermethrin (ΙΙ-3-17), theta-cypermethrin (ΙΙ-3-18 ), zeta cypermethrin (ΙΙ-3- 19), cyfenotrin [(1K) -trans isomers] (ΙΙ-3-20), deltamethrin (ΙΙ-3-21), empentrine [(ΕΖ) - (1Κ) isomers) (ΙΙ-3-22), esfenvalerate (ΙΙ-3-23), etofenprox (ΙΙ-3-24), fenpropatrin (ΙΙ-3-25), fenvalerate (ΙΙ-3-26), flucytrinate (ΙΙ-3-27), flumetrin (ΙΙ-3- 28), tau-fluvalinate (ΙΙ-3-29), halfeprox (ΙΙ-3-30), imiprotrin (ΙΙ-3-31), cadetrin (ΙΙ-3-32), permethrin (ΙΙ-3-33), phenotrin [(1K) -trans isomer) (ΙΙ-3-34), pralletrin (ΙΙ-3-35), pyrethrin (pyrethrum) (ΙΙ-3-36), resmetrin (ΙΙ-3-37), silafluofen (ΙΙ -3-38), teflutrin (ΙΙ-3-39), tetramethrin (ΙΙ-3-40), tetramethrin [(1K) -isomers)] (ΙΙ-3-41), tralomethrin (ΙΙ-3-42) and transflutrin (ΙΙ-3-43), or DDT (ΙΙ-3- 44); or methoxychlor (ΙΙ-3-45).

(4) Acetylcholine nicotinic receptor agonists (pASNA), e.g. neonicotinoids, e.g. acetamipride (ΙΙ-4-1), clothianidin (ΙΙ-4-2), dinotefuran (ΙΙ-4-3), imidacloprid (ΙΙ-4-4) nitenpyram (ΙΙ-4-5), thiacloprid (ΙΙ-4-6) and thiamethoxam (ΙΙ-4-7); or nicotine (ΙΙ-4-8).

(5) Allosteric activators of the nicotinic acetylcholine receptor (pASNA), e.g. spinosyns, e.g. spinetorams (ΙΙ-5-1) and spinosad (ΙΙ-5-2).

(6) Chloride channel activators, e.g. avermectins / milbemycins, e.g. abamectin (ΙΙ-6-1), emamectin benzoate (ΙΙ-6-2), lepimectin (ΙΙ-6-3), milbemectin (ΙΙ-6-4).

(7) Mimics of juvenile hormone, for example analogues of juvenile hormone, for example, hydroprene (ΙΙ-7-1), kinoprene (ΙΙ-7-2), and methoprene (ΙΙ-7-3); or phenoxycarb (ΙΙ-7-4); or pyriproxyphene (ΙΙ-7-5).

(8) Versatile non-specific (repeatedly occurring) inhibitors, for example alkyl halides, for example methyl bromide (ΙΙ-8-1) and other alkyl halides, or chloropicrin (ΙΙ-8-2); or sulfur fluoride (ΙΙ-8-3); or borax (ΙΙ-8-4); or potassium antimonyl tartrate (ΙΙ-8-5).

(9) Selective homopteran feeding blockers, for example, pymetrosine (ΙΙ-9-1); or flonicamide (ΙΙ-9-2).

(10) tick growth inhibitors, for example clofentesin (ΙΙ-10-1), hexithiazox (ΙΙ-10-2) and diflovidazine (ΙΙ-10-3); or ethoxazole (ΙΙ-10-4).

- 10 027125 (11) Microbiological destroyers of the membranes of the middle intestine of insects, for example, VasShik TNPepyk subspecies (ΙΙ-11-1), VasShik krNaepsik (ΙΙ-11-2), VasShik TNIPpDepyk subspecies τίζΗλΥτί (Ш-ШппНН, the subspecies khLaSh (ΙΙ-11-4), VasShik TnippDepyk subspecies (bilobar (ΙΙ-11-5) and BT proteins of cultivated plants: Cg1L, Cg1Ac, Cg1Pa, Cg2Ab, mCg3A, Cg3Al, Cg3B1, Cg34 / 35A 6).

(12) Mitochondrial ATP synthase inhibitors, e.g. diafentiuron (ΙΙ-12-1), or organotin miticides, e.g. azocyclotin (ΙΙ-12-2), cyhexatin (ΙΙ-12-3), phenbutatin oxide (ΙΙ-12-4 ); or propargite (ΙΙ-12-5); or tetradiphone (ΙΙ-12-6).

(13) Oxidative phosphorylation uncoupling agents through the destruction of the proton gradient, for example, chlorphenapyr (ΙΙ-13-1), DNOC (ΙΙ-13-2) and sulfuramide (ΙΙ-13-3).

(14) Acetylcholine nicotinic receptor channel blockers (IACS), e.g. bensultap (ΙΙ-14-1), cartap hydrochloride (ΙΙ-14-2), thiocyclam (ΙΙ-14-3) and sodium thiosultap (ΙΙ-14-4) .

(15) Chitin biosynthesis inhibitors, type 0, e.g. bistiflugon (ΙΙ-15-1), chlorfluazuron (ΙΙ-152), diflubenzuron (ΙΙ-15-3), flucycloxuron (ΙΙ-15-4), flufenoxuron (ΙΙ-15 -5), hexaflumuron (ΙΙ-15-6), lufenuron (ΙΙ-15-7), novaluron (ΙΙ-15-8), noviflumuron (ΙΙ-15-9), teflubenzuron (ΙΙ-15-10) and triflumuron (ΙΙ-15-11).

(16) Type 1 chitin biosynthesis inhibitors, e.g. buprofesin (ΙΙ-16-1).

(17) Shedding agents, for example, cyromazine (ΙΙ-17-1).

(18) Ecdysone receptor agonists, e.g. chromaphenoside (ΙΙ-18-1), halofenoside (ΙΙ-18-2), methoxyphenoside (ΙΙ-18-3) and tebufenoside (ΙΙ-18-4).

(19) Octopamine receptor agonists, e.g. amitraz (ΙΙ-19-1).

(20) Inhibitors of electron transport of the mitochondrial complex ΙΙΙ, for example, hydramethylnon (ΙΙ-20-1); or acequinocyl (ΙΙ-20-2); or fluacripyrim (ΙΙ-20-3).

(21) Inhibitors of electron transport of the mitochondrial complex Ι, e.g. ΜΕΉ acaricides, e.g. phenazachine (ΙΙ-21-1), fenpiroximate (ΙΙ-21-2), pyrimidiphene (ΙΙ-21-3), pyridaben ((-21-4) , tebufenpyrad (ΙΙ-21-5), tolfenpyrad (ΙΙ-21-6) or Rotenon (Oegpk) (ΙΙ-21-7).

(22) Blockers of voltage-gated sodium channels, for example indoxacarb (ΙΙ-22-1) or metaflumizone (ΙΙ-22-2).

(23) Acetyl CoA carboxylase inhibitors, e.g., tetronic and tetramic acid derivatives, e.g., spirodiclofen (ΙΙ-23-1), spiromesifen (ΙΙ-23-2), and spiro tetramate (ΙΙ-23-3).

(24) транспортаν mitochondrial complex electron transport inhibitors, e.g. phosphines, e.g. aluminum phosphide (ΙΙ-24-1), calcium phosphide (ΙΙ-24-2), phosphine (ΙΙ-24-3) and zinc phosphide (ΙΙ-24- 4) or cyanide (ΙΙ-24-5).

(25) Inhibitors of electron transport of the mitochondrial complex ΙΙ, for example, cienopyrafen (ΙΙ-25-1).

(28) Ryanodine receptor modulators, e.g. diamides, e.g. chlorantraniliprol (лип-28-1) and flubendiamide (ΙΙ-28-2).

(29) Active ingredients with unknown or indeterminate mode of action, e.g. amidoflumet (ΙΙ-29-1), azadirachtin (ΙΙ-29-2), benclothiaz (ΙΙ-29-3), benzoximate (ΙΙ-29-4), biphenazate (ΙΙ-29-5), bromopropylate (ΙΙ-29-6), quinomethionate (ΙΙ-29-7), cryolite (ΙΙ-29-8), cyanthraniliprol (cyazipyr) (ΙΙ-29-9), tsiflumetophen (ΙΙ -29-10), dicofol (ΙΙ-29-11), diflovidazine (ΙΙ-29-12), fluensulfone (ΙΙ-29-13), flufenerim (ΙΙ-29-14), flufiprol (ΙΙ-29-15) , fluopyram (ΙΙ-29-16), fufenoside (ΙΙ-29-17), imidaclotis (ΙΙ-29-18), iprodione (ΙΙ-29-19), meperflutrin (ΙΙ-29-20), pyridylyl (ΙΙ- 29-21), pyrifluquinazone (ΙΙ-29-22), tetramethylflutrin (ΙΙ-29-23) and iodomethane (ΙΙ-29-24); in addition, products based on VasShik Shgtik (including, but not limited to, the strain СЫСМ Ι-1582, such as, for example, νΟΉνΟ ™, Vyuyet) (ΙΙ-29-25) or one of the following known active compounds:

3-bromo-Y- {2-bromo-4-chloro-6 - [(1-cyclopropylethyl) carbamoyl] phenyl} -1- (3-chloropyridin-2-yl) -1Npyrazole-5-caboxamide (ΙΙ-29- 26) (known from MO 2005/077934),

4- {[(6-bromopyridin-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one MO 2007/115644), (ΙΙ-29-27) (famous of 4 - {[(6-fluoropyridin-3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one (ΙΙ-29-28) MO 2007/115644), (famous of 4- {[(2-chloro-1,3-thiazol-5-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one MO 2007/115644), (ΙΙ-29-29) (famous of 4- {[(6-chloropyridin-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one MO 2007/115644), flupiradifuron (ΙΙ-29-31) (known from MO 2007/115644), (ΙΙ-29-30) (famous of 4- {[(6-chloro-5-fluoropyridin-3-yl) methyl] (methyl) amino} furan-2 (5H) -one MO 2007/115643), (ΙΙ-29-32) (famous of 4 - {[(5,6-dichloropyridin-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (ΙΙ-29-33) (famous of

MO 2007/115646),

4 - {[(6-chloro-5-fluoropyridin-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (P-29-34) (known

- 11 027125 of No. 0 2007/115643),

4 - {[(6-chloropyridin-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (11-29-35) (known from

EP-A-0539588),

4 - {[(6-chloropyridin-3-yl) methyl] (methyl) amino} furan-2 (5H) -one (11-29-36) (known from

EP-A-0539588), {[1- (6-chloropyridin-3-yl) ethyl] (methyl) oxide-X4-sulfanylidene} cyanamide (11-29-37) (known from No. 0 2007/149134) and its diastereomers {[(1K) -1- (6-chloropyridin-3-yl) ethyl] (methyl) oxide-X4 sulfanilidene} cyanamide (A) (11-29-38) and {[(18) -1- (6- chloropyridin-3-yl) ethyl] (methyl) oxide-X4 sulfanilidene} cyanamide (B) (11-29-39) (also known from No. 0 2007/149134), as well as sulfoxaflor (11-29-40) from No. 0 2007/149134) and its diastereomers [(K) -methyl (oxide) {(1K) -1- [6- (trifluoromethyl) pyridin-3-yl] ethyl} -X4-sulfanilidene] cyanamide (A1) ( 11-29-41) and [(8) -methyl (oxide) {(18) -1- [6- (trifluoromethyl) pyridin-3-yl] ethyl} -X4 sulfanilide n] cyanamide (A2) (11-29-42), referred to as a group of diastereomers A (known from No. 0 2010/074747, No. 0 2010/074751), [(K) -methyl (oxide) {(18) -1 - [6- (trifluoromethyl) pyridin-3-yl] ethyl} -X4-sulfanylidene] cyanamide (B1) (11-29-43), [(8) -methyl (oxide) {(1K) -1- [6 - (trifluoromethyl) pyridin-3-yl] ethyl} -X4-sulfanylidene] cyanamide (B2) (11-29-44), referred to as the diastereomer group B (also known from No. 0 2010/074747, No. 0 2010/074751) ,

11- (4-chloro-2,6-dimethylphenyl) -12-hydroxy-1,4-dioxa-9-azadispiro [4.2.4.2] tetradec-11-en-10-one (11-29-45) (known from No. 0 2006/089633),

3- (4'-fluoro-2,4-dimethylbiphenyl-3-yl) -4-hydroxy-8-oxa-1-azaspiro [4.5] dec-3-en-2-one (11-29-46) ( known from No. 0 2008/067911),

1- {2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl} -3- (trifluoromethyl) -1H-1,2,4-triazole-5amine (11-29- 47) (known from No. 0 2006/043635), [(38.4aK, 12K, 12a8,12b8) -3 - [(cyclopropylcarbonyl) oxy] -6,12-dihydroxy-4,12b-dimethyl-11-oxo9- (pyridin-3-yl) -1,3,4,4a, 5,6,6a, 12,12a, 12b-decahydro-2H, 11H-benzo [1] pyrano [4,3-b] chromene-4yl] methylcyclopropane-carboxylate (11-29-48) (known from No. 0 2008/066153),

2- cyano-3- (difluoromethoxy) -X, X-dimethylbenzenesulfonamide (11-29-49) (known from No. 0 2006/056433),

2-cyano-3- (difluoromethoxy) -Y-methylbenzenesulfonamide (11-29-50) (known from No. 0 2006/100288),

2- cyano-3- (difluoromethoxy) -Y-ethylbenzenesulfonamide (11-29-51) (known from No. 0 2005/035486),

4- (difluoromethoxy) -Y-ethyl-X-methyl-1,2-benzothiazole-3-amine 1,1-dioxide (11-29-52) (known from No. 0 2007/057407),

Y- [1- (2,3-dimethylphenyl) -2- (3,5-dimethylphenyl) ethyl] -4,5-dihydro-1,3-thiazol-2-amine (11-29-53) (known from No. 0 2008/104503), {1 '- [(2E) -3 - (4-chlorophenyl) prop-2-en-1-yl] -5-fluorospiro [indole-3,4'-piperidine] -1 ( 2H) -yl} (2chloropyridin-4-yl) methanone (11-29-54) (known from No. 0 2003/106457),

3- (2,5-dimethylphenyl) -4-hydroxy-8-methoxy-1,8-diazaspiro [4.5] dec-3-en-2-one (11-29-55) (known from No. 0 2009/049851 ),

3- (2,5-dimethylphenyl) -8-methoxy-2-oxo-1,8-diazaspiro [4.5] dec-3-en-4-yl-ethyl carbonate (11-29-56) (known from No. 0 2009/049851 ),

4- (but-2-in-1-yloxy) -6- (3,5-dimethylpiperidin-1-yl) -5-fluoropyrimidine (11-29-57) (known from No. 0 2004/099160), (2 , 2,3,3,4,4,5,5-octafluoropentyl) (3,3,3-trifluoropropyl) malononitrile (11-29-58) (known from No. 0 2005/063094), (2.2.3 , 3,4,4,5,5-octafluoropentyl) (3,3,4,4,4-pentafluorobutyl) malononitrile (11-29-59) (known from No. 0 2005/063094),

8- [2- (cyclopropylmethoxy) -4- (trifluoromethyl) phenoxy] -3- [6- (trifluoromethyl) pyridazin-3-yl] -3azabicyclo [3.2.1] octane (11-29-60) (known from No. 0 2007/040280),

2-ethyl-7-methoxy-3-methyl-6 - [(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) oxy] quinoline4-ylmethyl carbonate (11- 29-61) (known from YP2008 / 110953),

2-ethyl-7-methoxy-3-methyl-6 - [(2,2,3,3-tetrafluoro-2,3-dihydro-1,4-benzodioxin-6-yl) oxy] quinoline 4-yl acetate (11- 29-62) (known from 1P2008 / 110953).

PP1364 (CA8-Ked. 120ο. 1204776-60-2) (11-29-63) (known from 1P2010 / 018586),

5- [5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2- (1H-1,2,4-triazol-1yl ) benzonitrile (11-29-64) (known from No. 0 2007/075459),

5- [5- (2-chloropyridin-4-yl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2- (1H-1,2,4-triazole -1il) benzonitrile (11-29-65) (known from No. 0 2007/075459),

4- [5- (3,5-dichlorophenyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2-methyl ^ - {2-oxo-2 [(2 , 2,2-trifluoroethyl) amino] ethyl} benzamide (11-29-66) (known from No. 0 2005/085216),

- 12 027125

4- {[(6-chloropyridin-3-yl) methyl] (cyclopropyl) amino} -1,3-oxazole-2 (5H) -one (11-29-67),

4 - {[(6-chloropyridin-3-yl) methyl] (2,2-difluoroethyl) amino} -1,3-oxazol-2 (5H) -one (P-29-68),

4- {[(6-chloropyridin-3-yl) methyl] (ethyl) amino} -1,3-oxazole-2 (5H) -one (P-29-69),

4 - {[(6-chloropyridin-3-yl) methyl] (methyl) amino} -1,3-oxazol-2 (5H) -one (P-29-70) (all known from

AO 2010/005692),

NN1-0711 (11-29-71) (known from AO 2002/096882),

-acetyl-Shch4- (1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl) -3-isobutylphenyl] A-isobutyryl-3.5dimethyl-1H-pyrazole-4-caboxamide (11- 29-72) (known from AO 2002/096882), methyl 2- [2 - ({[[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) -5-chloro-3methylbenzoyl] -2-methylhydrazinecarboxylate (11-29-73) (known from AO 2005/085216), methyl 2- [2 - ({[3-bromo-1 - (3-chloropyridin-2-yl) ) -1H-pyrazol-5-yl] carbonyl} amino) -5-cyano-3 methylbenzoyl] -2-ethylhydrazinecarboxylate (11-29-74) (known from AO 2005/085216), methyl 2- [2 - ({ [3-bromo-1 - (3-chloropyridin-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) -5-cyano-3 methylbenzoyl] -2-methylhydrazinecarbox lat (11-29-75) (known from AO 2005/085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1 - (3-chloropyridin-2-yl) -1H- pyrazole-5yl] carbonyl} amino) benzoyl] -1,2-diethylhydrazinecarboxylate (11-29-76) (known from AO 2005/085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo -1 - (3-chloropyridin-2-yl) -1H-pyrazol-5yl] carbonyl} amino) benzoyl] -2-ethylhydrazinecarboxylate (11-29-77) (known from AO 2005/085216), (5K§, 7K §; 5K§, 7§K) -1- (6-chloro-3-pyridylmethyl) -1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5propoxyimidazo [1,2- a] pyridine (11-29-78) (known from AO 2007/101369),

2- {6- [2- (5-fluoropyridin-3-yl) -1,3-thiazol-5-yl] pyridin-2-yl} pyrimidine (11-29-79) (known from AO 2010/006713) ,

2- {6- [2- (pyridin-3-yl) -1,3-thiazol-5-yl] pyridin-2-yl} pyrimidine (11-29-80) (known from AO 2010/006713),

1- (3-chloropyridin-2-yl) - ^ [4-cyano-2-methyl-6- (methylcarbamoyl) phenyl] -3 - {[5- (trifluoromethyl) -1Hetetrazol-1-yl] methyl} -1H pyrazole-5-caboxamide (11-29-81) (known from AO 2010/069502),

1- (3-chloropyridin-2-yl) - ^ [4-cyano-2-methyl-6- (methylcarbamoyl) phenyl] -3 - {[5- (trifluoromethyl) -2Htetrazol-2-yl] methyl} -1H -pyrazole-5-caboxamide (11-29-82) (known from AO 2010/069502), ^ [2- (tert-butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3-chloropyridin-2- il) -3 - {[5- (trifluoromethyl) 1H-tetrazol-1-yl] methyl} -1H-pyrazole-5-caboxamide (11-29-83) (known from AO 2010/069502), ^ [2- (tert-butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3-chloropyridin-2-yl) -3 - {[5- (trifluoromethyl) 2H-tetrazol-2-yl] methyl} -1H-pyrazole -5-caboxamide (11-29-84) (known from AO 2010/069502), (1E)-Щ (6-chloropyridin-3-yl) methyl] -№-cyano - ^ (2,2-difluoroethyl) ethanimidamide (11-29-85) (known from AO 2008/009360), ^ [2- (5-amino-1,3,4-thiadiazol-2-yl) -4-chloro-6-methylphenyl] -3-bromo-1- (3-chloropyridin-2 -yl) -1Npyrazole-5-caboxamide (11-29-86) (known from ΟΝ102057925) and methyl 2- [3,5-dibromo-2 - ({[[3-bromo-1 - (3-chloropyridin-2- il) -1H-pyrazol-5yl] carbonyl} amino) benzoyl] -2-ethyl-1-methylhydrazinecarboxylate (11-29-87) (known from AO 2011/049233).

In a preferred embodiment, the insecticide is selected from the group of: clothianidin, imidacloprid, thiacloprid, thiamethoxam, acetamipride, methiocarb, thiodicarb, beta-cyfluthrin, cyfluthrin, deltamethrin, teflutrin, indoxacarb, spinosad, spinetoram, fipromenfen, etroflomenfen, etipromenfen, ethipromenfen, etipromenfen, etipromenfen, etioprofenamel, etipromenfen, etioprofenamel, etiproclin, etiopromenfin, etiopromenfin, etiopromenfin, etiopromenfin, etiopromenfin, etiropromenf , spiromesifen, spiro tetramate, flubendiamide (K), (§) -3-chloro - ^ - {2-methyl4- [1,2,2,2-tetrafluoro-1- (trifluoromethyl) ethyl] phenyl} - ^ - (1 -methyl-2-methylsulfonylethyl) phthalamide, chlorantraniliprol (Kupachurug) or cyanthraniliprol (Sua / urug), sulfoxaflor, VasShik tick strain 0Ν0Μ 1-1582.

In another preferred embodiment, the insecticides are selected from the group:

4 - {[(6-bromopyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from AO 2007/115644),

4- {[(6-fluoropyrid-3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one (famous of AO 2007/115644), 4- {[(2-chloro-1,3-thiazol-5-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one AO 2007/115644), (famous of 4- {[(6-chloropyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from AO 2007/115644), 4- {[(6-chloropyrid-3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one, AO 2007/115644), famous of 4 - {[(6-chloro-5-fluoropyrid-3-yl) methyl] (methyl) amino} furan-2 (5H) -one AO 2007/115643), (famous of 4 - {[(5,6-dichloropyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one AO 2007/115646), (famous of 4 - {[(6-chloro-5-fluoropyrid-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one AO 2007/115643), (famous of

4 - {[(6-chloropyrid-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (known from EP-A-0539588),

- 13 027125

4 - {[(6-chloropyrid-3-yl) methyl] (methyl) amino} furan-2 (5H) -one (known from EP-A-0539588).

The following biological control agents, in particular bacteria, fungi or yeast, protozoa, viruses, entomopathogenic nematodes, inoculants and plant agents, can be used in combination with a compound corresponding to the formula (I) fluopyram:

Examples of such bacteria that are used or are used in accordance with the invention are:

(1.1) ArgoBac1gsth gaiyuGasuG, (1.2) VaShiz alShO1SGGS51g15, (1.4) VaShiz a1 / a \ wak (1.6) VaShiz a1 / a \ wak (1.6) VaShiz a1bO1asyz, (1.7) , (1.9) Vasyshiz atomodulisis, Phisis, (1.10) Vasyshizis arisensis, (1.11) Vasyshizus arisensis, (also known as Raeschaschisus arisensis), (1.12) Vasyshizus arisensis, known as the strain 1N937Ba, or, strain B3, (1.13) Vasyshiz apeyshyloisis, (1.14) Vasyshiz ayorakayiz, (1.15) Vasyshiz a / o Yugogtapz, (1.16) Vasyshiz seisis, (1.17) Vasyshiz segeiz (synonyms: Vasyshiz epysogusisus, Vasilisus) , in particular, the disputes of B. segeis of strain CYSM 1-1562 (see I8 6406690), (1.18) Vaselis cisosarz, (1.19) Vasilis cislaris, (1.20) Vasilis celisaris, (1.21) Vasylarrhiziasis (human pathogen), (1.22) VasShiz Gazyyuyuziz, (1.23) VasShiz kaszakak (1.25) Vasi Shiz kaszak, (1.25) Vasi Shiz kaszak, (1.26) Vasi Shiz kaszogiz, (1.26) Vasi Schiz yasiz, 1.26 ) Bacillus lucidis (also known as Brinococcus laris), (1.29) Bacillus cucumis, (1.30) Bacillus lucensis, (1.31) Bacillus lucensis, (1.32) Bacillus cirrhisus, (1.33) Ukty, known as VyuLgs), (1.35) Vasi Shiz tusoiz, (1.36) Vasi Shiz payo, (1.37) Vasiiz peta, (1.38) Vasiiz tiysapz, (1.39) Vasiiz tiysapz, (1.40) Vasiiz tizi, (1.41) Vasi , (1.42) Bacillus pylori (products known as Cranococcus aureus), (1.43) Bacillus cactus rhizocensis, (1.44) Bacillus cirrhiza, in particular strain CB34 (products known as U1e1y 8Be1y®) and strain C8T2808 (products known as 8O8a1 ®), (1.45) Vasiliz sigmais, (1.46) Vasilizis sppi, (1.47) Vasilizis erythroxis (products known as UesFiex®), (1.48) Vasilizis erythrocytes, in particular strain CB03 (products known to to KoFak®) and O8T strain 713 (products known as 8egepaye O8T 713®), or B. subtilis var. atuFiszyuGaaepz strain P2B24 (products known as Taedgo®), (1.49) Vasyshiz sigenschildis, in particular B. sigischis sar. 1gr1l3l3z (products known as Ves1oBac®), or B. Shigdzhepzi3 zlzr. A1 / a \\ ni strain ABT8-1857 (products known as HepTap®), or

- 14 027125

V.Shigtd1epk1k kykr. Chrya strain штам-1 (products known as Όίρβΐ® Εδ), or B. Shigtd1epk1k kykr. 1peepyushk strain ΝΒ 176 (products known as ΝονοάοΓ® EC), or W. Sh. Schöder (products known as Adepp), or B. 1H. var. soptep (products known as IapVaoVTs), or B. 1H. var. Eagtk1aE1epk1k (products known as VasNipp, Ko1er1epp), or V. Sh. EneGoNoTic (products known as PepeGoanths), or B. 1H. var. daepae ((products known as Eeebacacep), or B. 1H. var. | aropepec (products known as ViHiegie), or V.N. kikr. Motkosh, or B. 1N. va. cap E1edo, or V. Sh Klkr. 11shppd1epk1k strain MPP002, or V. Sh. var. Shigtd1epk1k (products known as B1ko1), or B. 1k var 7216 (products known as AtacEC, ReEyap), or V. L. var T36 (products known such as CaNa1), (1.50) VasHik unIpade11a1ik, (1.51) Vaeuyu / oiit _) arotsite (8nuyuyu1, products known as 5OeGe1e1), (1.52) Vaeuuuuuuuuuu (formerly VaSuyuuuuuu8), in particular 3, δδ86-4, δδ86-5,

2904, (1.53) VGeuShasShik 1a1egokrogpk (in the past VasShik 1a1egokrogpk), in particular strains 64, 1111, 1645, 1647, (1.54) CHrothobacillus kiMkidae, in particular the strain RKLL4-1T (products known as SapEeuuhoge), (1. in particular, strain ΚΑΥ209 (products known as VyVook! ®), (1.56) Lomobactylus espens (products known as Eglncap), (1.57) Lactobacillus aepticus, in particular strain 13-1 (see, Vulobox1Cop1go1. , 288-296), (1.58) Lactobacillus nucifera, in particular strain C3 (see, 1. No. On1. 2006. Type; 38 (2): 233-239), (1.59) strains ΙΙΙ3ΌΤ-1Α, ΙΙΙ2Ε, 46С3, 2771 (Center Bacillus Genetic Fund (VasShik depeEs kyusk seSheg), November 2001), (1.60) RaetbasShik roputa, (1.61) Raesbashek rarPae (in the past VasiShik roeRenaye), (1.62) RaShoea addlotegapk, (1.63) Raekekeepee, products known as wetting powder RakYunpa, (1.64) RakYunpa ikdae (products known as Esope! ™), (1.65) RESiuasYupit sago1ouoglt (formerly Er \\ Epa sagoUuoga) products known as B® oKeereg, (1.66) Rokeyoshopokaeg (products known as CuSiS), (1.67) RkeiEotopak aigeoKashepk (products known as Ada1e-25K), (1.68) RkeiEot opak serash (in the past, known as VigkNo1EeEa serasha), in particular strains M54 or 182, (1.69) RkeiEotopak with MogogarMk, in particular strain MA 342 (products known as CeEotop), (1.70) Rkieiotopak Piogeksepk (products known as EEEo / ope), (1.71) RkeiEotopak rgogaShkh (products known as RgogaShkh®), (1.72) RkeiEotopak ripea (products known as Nyta! kSh, (1.73) RkeiEotopak hekshouogapk (products known as 8o1apasige), (1.74) kupeeakopot (products known as Vukaue), (1.75) 8eggaEa eShotornPa (products known as damaging), (1.76) cspec, in particular strain δ М (MTCC8708) or strain K35, (1.77) 8 Epericus nigella (products known as CuAlE®), (1.78) 8 Epericus cepoteric (products known as Musoceche), (1.79) Esperus, in particular K61 (products known as Musok1or®, see Sgor Rgo1esEop 2006, 25, 468-475) or strain C8T 6047, (1.80) 8Eer1worms dokNPeepk® (products known as EaGedgo), (1.81) 8Eer1worms dkkeoutShk (products known like MusokYur®, see MyuOi1 Eb oG SapaEa), (1.82) 8Eer1 nipples 1auepEi1ae (products known as RNu1o1aush-300, (1.83) 8Eer1 nibs 1uEyuik, in particular strain \ νΥί'Ό108 (n products known as AcBpoa1e8P) or strain \ νΥΕί'ΥΕί08 (products known as AcBpoa-Eop), (1.84) 8Eer1 cones of rhakshik (see Rgakshopk A apE B: ro1ep! 1pcIcIecEc Ggot 8Eep1carabatum papillon ArrnEe thuGodiu 1973 no. (herbicidal activity), (1.89) Hepognabeic acid, (1.90) Hepoganicobacterium.

- 15 027125

Biological controls that are generalized to mushrooms or yeast are:

(2.1) Lactobacillus sciaticaPc, in particular the AO 10 strain (product known as AO 10®), (2.2) Aiguella-81stri11i1ap8, in particular the blastospores of strain Ό8Μ14940 or the blastospores of strain Ό8Μ14941 or a mixture thereof (product known as B1ococcus Prgo) 2.3) AxGnkota a1eugojek, (2.4) AkregdSik yauik, in particular the strain ICKL 21882 (products known as Ay-Siagy®), (2.5) Ayngojuyuk kirigba (Sogya 1839), (2.6) Veiuepa bakkapa, in particular the strain ATC40 known as Na1a118®) and the CHA strain (products known as Musoyo1, Bo1asCagy), (2.7) Veiuepa идgoidsheyp (products known as Beairgo), (2.8) Сапй | йа о1еорНя, in particular strain О (products known as Nxu®, Acrie), (2.9) СаеУпиит иргеит (products known as Ке1осш), (2.10) С1йокрогшт с1айокропо1йек, in particular the strain H39, (2.11) SoshyuO1ik oksigik, (2.12) Soshyuugsti tiShapk, in particular the SOY / M / 91-8 strain (products known as Soshaik®), (2.13) OmniRegal a1resst (products known as T \\ zk1 Riidik®) , (2.14) ANOTHER SHOULDER (products known as UEC1Og), (2.15) Ricagic oxycrogite, in particular the Po47 strain (non-pathogenic) (products known as Ricas1eap), (2.16) in particular, strain ί 1446 (products known as Przecor® or Przipakyur), (2.17) Nyk1e11a (Notrkopi (products known as MusoNy or ABTEC), (2.18) nadeshysh dldayeit (products known as Ladshex® from Acycloe). , (2.19) Hessococcidae esapi (in the past, known as UeFciccone 1esapl), in particular, the conidia of strain KU01 (products known as Muso1a1®, Ug1a1ec®), (2.20) Me1ag sulcidae, in particular strain P52 (products known as B1O 1020 or Me (52) or M. a. var aspiit (products known as Szheep Miks1e), (2.21) Me1ag ^ shsh ya yo \ zpye, (2.22) Me1xNshko \ for Ghysiso1a, in particular strain IKKB 30-30752 (a product known as 8Geget®), (2.23) M | sokrNaegork1k osNgasea (products known as Muhokh®), (2.24) Misog NatePk (product known as VyuAuagy), (2.25) Miksoyog a1bik, in particular strain Ο8Τ 20799 (products known as Agaexche ™ or Apyashe6), ) Mugo ш у у у г г ис ап ап,, штам, in particular strain AAX-0255 (products known as ONEG ™), (2.27) Yotigaea geug, in particular strains 8A86101, SI87401, 8K86151, CC128 and UA9101 (products known as Kopd ®), (2.28) OrNyukuta Reisgit, in particular strain Ό97 (products known as 8u1uaieh), (2.29) Raisyoshusek Gitokogeik, in particular strain aroka 97 (products known as RgeReKa1), (2.30) Raysyoshusek Shraschik, in particular spores . Schaschik strain 251 (products known as VyuAc1®, see Sgor RgoEesoyoi 2008, 27, 352-361), (2.31) Rasyotusek uapoog in particular strain 0-09 (products known as Metadi ™), (2.32) Rapyoga yefNas ® (2.33) Resolution III, in particular the strain ATCC22348 (products known as ^ ishr§ΐa ^ ι®, PB-50, Protez), (2.34) Reshspit, νе ^ ш ^ siаΐish (products known as Uepshshep), (2.35 ) РЫеЫырык (= РН1еЫа = ReshorNoga) d1dEeaa (products known as CoekeEor), (2.36) RyuOa apota1a, in particular, strain RB-076, (2.37) Rosnosh syuatuyokropa, (2.38) Rkeyo osusha Yossiu Roca (in particular products known as 8rogyex® b), (2.39) RuENstin oPdai, in particular strain EU74 (products known as RoKuegkit), (2.40) BrogoENpx tkesUgit (products known as 8rogyextx), (2.41) Ta1agotusek Lauik, (2.42 ) TpsNoyegta a1Lit (products known as Bju ^ eI), (2.43) TpsNoyegta akregepit, in particular strain 1CC 012 (products known as B | o1ei®), (2.44) TpsNoyegta datki (in Roshlom T. \ zpye), in particular, mycelial fragments, conidia and chlamydospores of strain 1СС080 (products known as Wuyegt), (2.45) TpsNoyegta Nappaipp,

- 16 027125 (2.46) TpNoiegta Lapapit, in particular T. Lapnapit T39 (products known as Tpnoyeh®), (2.47) TpNoiegta kotpdn (products known as Tpco1-5> P1i8), (2.48) TpsNoiegta Ndpogit (products, as Muso bac), (2.49) TpNoiegert ro1u8 rogite, in particular strain ΙΜΙ 206039, (2.50) TpnNoiegert νίτβηδ (in the past OPO1aytt νίτβηδ), (products known as BOPOagy), (2.51) ), (2.52) Ulocylacticonium (products known as Bilogu-2ep), (2.53) Unicornicum ailobactum, in particular strain C8850, (2.54) Unicorniculatum (product you known as UashNa), (2.55) UeShsShsht yaNPae (products EShsN known as TPD) and (2.56) 2oorN1oga gaShsapk. Biological controls, which are summarized in the concept of the simplest, are:

(3.1) Yoketa osi81e (products known as 1 1 В В ай ай))), (3.2) ТНе1 ата ата о о 1 еп ор 8 8 18 18 и и ((((((((3.3)

Biological controls that are summarized in the concept of viruses are:

(4.1) AyochorNuek ogapa (reticulata leaflet) granulosa virus (OS), (a product known as VURL - Sarekh®), (4.2) Adgoik 8de1iit (winter scoop) nuclear polyhedrosis virus (PRU), (4.3) Lpysag81a detta1aN8 (wool pyrrhiza moth) TPRU (products known as Po1udep), (4.4) ASHODGARNA saPGisa (Californian alfalfa scoop) TPRU (products known as ΎΡΝ80 from Adpso1a E1 §O1), (4.5) VSHop 5irge55apa (tea moth) PRU, (4.6) top (silkworm) PRU, (4.7) Sgur1orN1eSha 1enso1ge1a (false codling moth) OU (products known as Sgur1ekh), (4.8) Sysha rotope11a (p apple ripple) granulosa virus (OS) (a product known as Mayekh P1i5), (4.9) Oepygoytnh rnps1a1n5 (silkworm pine Masons) SRU, (5.0) NePsogera agnidega PRU (a product known as AdVGGesN - U1Ui) Nepsogegra (formerly NOT GOOD) ζеа (cotton scoop) ПРУ (products known as Е1саг), (5.2) Леисота 8аПс18 (silkworm, willow) ПРУ, (5.3) Напапа и Ераг (silkworm unpaired), ПРУ (products known as Оурнесск), ( 5.4) PeoShrgup ASHESH (fir sawfly) PRU (products known as ASHEnu), (5.5) PeoShrgup 1esop1e1 (pine red sawfly) PRU (pr products known as EsopMgsh), (5.6) PeoShrgup keSHeg (ordinary pine sawfly) PRU (products known as NoosNesk-§), (5.7) Ogdu1a p8eyiyo18ida1a (bagpipe pseudotsugovaya) PRU (products known as UyShkk), RNShoptaea oreggi1e11a (potato tuber moth) DU (products known as Ma1aro1), (5.9) P1eSh garae (white meat) DU, (6.0) P1i1e11a xu1o§1e11a (cabbage moth) DU (products known as R1i1es), (6.1) royor! ega a1i1a (caterpillar of a moth with gray veins) tPRU (products known as URP

82), (6.2) §royor! Ega exp (true caterpillar) tPRU (products known as caterpillar of sugar beet), (6.3) §royor! Ega ejetia (caterpillar of sugar beet) tPRU (products known as §reh Ggot Apyegta and Vusopysh) , (6.4) §royor! Ega Ggid1regya (scoop grass) tPRU (products known as Vasn1ou | gn5 URP), (6.5) §royor! Ega NyogaSh (tobacco scoop) PRU (products known as BroyorShp from PRR SaShore Rtapse) and (6.6) §royor! Ega Shiga (oriental scoop) of the PRU (products known as bogs).

Biological controls that are generalized to the concept of entomopathogenic nematodes are:

(5.1) Lebennaya saisakua, (5.2) Asiap 8pr., (5.3) Adnatiensporr (5.4) Apapuet 8rr., (5.5) Atrl1tegt18 8rr. 5.7) Sategota 8 pp., (5.8) S.'NP \ uooShe11a oooGyatepeig (5.9) Sop1oyu1epsNi8 8rr.,

- 17 027125 (5.10) Si1u1sheg1818 δρρ., (5.11) O1p1o1paepa δρρ., (5.12) EsrIoshegshs δρρ., (5.13) RShr) eu1sheg18 Shriaiaga, (5.14) Ca81goshegosh18 δρρоо, 5.1 (5.14). ье оу кра,, ((5.1 5.1 5.1 Л Л шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг шаг. U8, Slightly Slow, Slightly Slightly 8 / Actual, (5.18) Sec8Get18 δρρ., (5.19) Riyroshegsht δρρ., (5.20) 18Getted18 δρρ., (5.21) Egoshegshsh δρρ., (5.22), (5.22) §Ge8sep 5, (5.24) Me8sh1818 δρρ., (5.25) Chess8sh1818 δρρ., (5.26) No. 811u1eps1sh8 gui1o81, (5.27) Osuosuhshp δρρ., (5.28) , (5.31) Regulipexp, siPc18, (5.32) Pbbbbbbbbbbb, (5.33) Pku8a1or1ega δρρ., (5.34) Prgo1ge11a1i8 δρρ., (5.35) P1gudoaeppahera8b8bp8bp8bp8, pb8bp Ь и и 1 аг аг 8 8 8 818 δρρ., (5.39) δ ί ί ι ι ι ди 1 ап ап еп 8 8 18 18 ((, (5.40) 5> 1 ег ег ρ (= Neo-1 ί ί δ δ ρ ρ)))))))) § §)))), in particular B1o1or1a), or §! This is good kaai88e1 (products known as bakerye), or §1 hashieša baуe (products known as vyuyuyu), or §1 hashisha 8sar1ep8a (products known as ша 1 ас ас 8 8), or 1 ет аг е е!!!! 81shkaua1, (5.41) 5> 1r1kuipep1i8 re! Eg8ep1, (5.42) и Ъ и 1 ига δ ρ δρρ., (5.43) 5> 1 ш 1 ге 1 1 1 у еп с с 8 8 и и и и ((((((((((5.4 5.4

Biological controls that are summarized in the concept of grafting material are:

(C6.1) д го Ь Ю Ю ш δ δ ρ ρ ρ,, (ог ог (((С го го го и и и δ ии ((((((((((((ии ((ии ((((ии ии ии ии ии ии ии ии ии ии ии С С С С С С С С С С b δt δρρ., (С6.6) ВшкЬоМейя δρρ., in particular ВшкЬоМейя сераша (in the past Ryeioshopan serasha), (С6.7) С1да8рога δρρ., in particular С1д8рога shagodagIa, or С1д8rog rogue shoproperis. , in particular, Closh8, addglysh, or Closh8, baulshayish, or Closh8, cl2, or Closh8, ellipso1a, or Closh8, cla8b, bb, bb, bb, bb, bb, bb, bb, bb, bb, bb. 1assa1a, (C6.10) bastard8 δρρ., (С6.12) Р18оШЬи8 ипшогш, (С6.13) Реёёшопь δρρ., (С6.14) РЫ / ошш δρρ., in particular РЫ / ошш Ггейи, or Р1и / оппп 1едшто8агиш, or Рё / or РЫ / Ошшш ШОШЫ, or РЫ / Ошшш (ппоШ, or РЫ / Ошш 1гор1с1, (С.6.15) Ρΐιί / Ородоп ашу1ородоп, or Ρΐιί / Ородоп ГИМД1еЬа, or РЫ / Оородоп 1и1е1ипь, or РЫ / інпь, or the rhodope uSho8i11i8, or (C.6.16) §1goyoegsha δρρ., in particular

- 18 027125

8s1egoyegta sigshit, (C6.17) §sh11ik krr., In particular §sh11ik dgapi1a! Ek or §sh11ik rnps1a1ar1ek and (C6.18) §1ger! Osusk krr.

Biological controls that are summarized in the concept of plant agents are:

(C7.1) thymol, extracted, for example, from thyme (1yushik ui1dag1k), (C7.2) Indian azadirachta oil (L / aShgassa sfsa), and as such azadiractin, (C7.3) pyrethrum, an extract obtained from dried flower heads of various species of the genus TapaseSt, and as such pyrethrins (active components of the extract), (C7.4) extract from Sakk1a sdpsapk, (C7.5) wood extract OnakNa ataga (simaruba tree), (C7.6) rotenone, extract from the roots and stems of several tropical or subtropical plant species, especially those belonging to the genera Lopsyosagrik and Eegpk, (C7.7) extract from L1yit kayuit (chapel), (C7.8) kilaya, extract obtained from a concentrated purified extract of the outer layer of cambium Osh11a) a 5> Aropapa Moipa tree, (C7.9) sabadilla seeds (8aLaSh11a = § syoyoposaiopomidae), in particular, veratrin (extracted from seeds), (C7.10) Ryania, an extract obtained from the soil stalks of Ruash scissiuk, in particular, ryanodine (the active component of the extract), (C7.11) extract from U1xish a1bit ( mistletoe), (C7.12) extract from Tapasesti ui1dage (tansy), (C7.13) extract from ARENINA akshshshsh (wormwood), (C7.14) extract from Igce Shock (k apives), (C7.15) extract from Bushryuu shh oGystae (common comfrey), (C7.16) extract from Tgoraea t.) ik (South African watercress), (C7.17) leaves and bark of Tsiegsik (oak) (C7 .18) yellow mustard powder, (С7.19) seed oil SyeporoShish apShe1tShysit (marsotifolia leaf), (С7.20) dried leaves from Oguor1epk yih-tak (male fern), (С7.21) bark from Se1akyik appdi1aShk (Chinese nightshade bittersweet), (C7.22) extract from EdshkeShsh aguepke (field horsetail), (C7.23) chitin.

Biological controls, which are Products obtained by microorganisms, including proteins or secondary metabolites, are:

(B8.1) harpin (emitted by EgMsha atu1ouoga, products known as Nagr-Y-Tek ™, Meckepdeg®, Etr1ou ™, PrgoLs! ™).

In a preferred embodiment, the biological control agents are selected from the group:

(1.12) VasAchik inattentiveGaaepk, in particular strain IL937a, or strain ΡΖΒ42 (a product known as P1y / oYa1®), or strain B3, (1.17) VasShik seseik (synonyms: VasShik epyogyushok, Vasik Shik teika), in particular, spores the seceic of the strain СЫСМ 1-1562 (see, И8 6,406,690), (1.34) VasShik tedaegtt (products known as ВюЛгс), (1.44) VasShik retryik, in particular strain CB34 (products known as У1е1й §Ые1й®) and strain O8T2808 (products known as 5> opa1a C8T 2808®), (1.47) VasShik kryaepsik (products known as Uesuyekhk), (1.48) VasShik kiyyk, in particular strain CB03 (products known as KoShak®) TS8T strain 713 (products known as §egepaye TS8T 713®), or B. kiyyk var. atuoysneGas1epk strain ΡΖΒ24 (products known as Taedgo®), (1.49) VasShik Shigsh ^ epyk, in particular B.1yng1pd1epk1k var. 1kajeepk1k (products known as Ves1oBac®) or V. Shigshdepkk kykr. A1 / a \\ t strain LVT8-1857 (products known as HepTap®), or B. 11shppd1epk1k kibkr. kngk1ak | strain ΗΌ-1 (products known as E | pe1® E§), or B. Shigd1epk1kkkr. (Lepotox strain LB 176 (products known as Loyoog® EC), or B.! y. var. aydurSh (products known as Ledger), or B.! y. var. cepep (products known as IapVaVTs), or V.! Y. wag. Yaggya Shepyk (products known as Vasyigsh, 1 <o1er1epp), or V.! Y. wag. Yepygoyshik (products known as Iepygobasyyp), or V.! Y. wag. Da11epaye ((products known as Eyegobasip), or B.! y. var.) aropepeck (products known as Vshyiyeg), or B. 1st kykr. Motkosh, or V.! y. uag.cap Shedo, or V.! y. kikr. 1ng1pd1epk1k strain MPP002, or B.! Y. Var. 1Nig1pd1epk1k (products known as B1ko1), or B.! y. var 7216 (products known as Lshasyis, Reyyap), or V.! y. var T36 (products known as Sia!), (1.55) Ieia as Szosogapk, in particular strain ΚΛ. Υ209 (products known as WuWoock! ®),

- 19 027125 (1.56) Lactobacillus acinensis (products known as Prichkai), (1.57) Lactobacillus apiculosum, in particular strain 13-1 (see Buculodactyla. Soygo1. 2008, 45, 288-296), (1.58) it is young, in particular, strain C3 (see 1. No. HAL1. 2006. Type; 38 (2): 233-239), (1.59) Rajabacic alue1, in particular strains S3L-1Ά, S2Ε, 46C3, 2771 (Center for the genetic fund bacillus (VasShik depeys küsk sep (eq.) November 2001), (1.70) Rkeiyotopak Yaiogeksepk (products known as Riyo / ope), (1.71) Rkheyotopak rgogaLkh (products known as RgogaLx®), (1.72) Rkiyotopakriyya ( products known as Beta, (1.73) Hekshoogapk (products known as 8O1 apasige), (1.74) Rkeyotopak kuppay (products known as Vukaue), (1.75) 8eggaya eShotornPa (products known as invasive), (1.76) 8ggaya tagsepek, in particular, strain 8K8M8 or T8M8 M8 (M) K.35, (1.77) 81gerIutusec sapShyik (products known as VyuA1y ™), (1.78) 81gerItusek sulotum1K (products known as MusokMe), (1.79) 81gerItus nasalis, in particular strain K61 (products known as Musokhr®, Argus Rgo1syop, 2006, 25, 468-475) or strain C8T 6047.

When processing the seed, attention should mainly be paid to the amount of fluopyram according to the invention applied to the seed and / or the amount of additional additives to be applied and selected so that the germination of the seed does not have a negative effect or that the resulting the plant was not affected. It should be borne in mind, in particular, that in the case of active compounds there may be phytotoxic effects at certain application rates.

In accordance with the invention, all plants and parts of plants can be processed. By plants are meant all plants and plant populations, such as desirable and undesirable wild plants, cultivated plant varieties and plant varieties (or unprotected plant varieties or with breeders' rights). Cultivated plant varieties and plant varieties can be plants obtained by conventional distribution and selection methods, which can take part or be supplemented by one or more biotechnological methods, such as using double haploids, fusion of protoplasts, arbitrary and directed mutagenesis, molecular or genetic markers or, using bioengineering and genetic engineering methods. By plant parts is meant all above-ground and underground parts and organs of plants, such as shoots, leaves, color and root, according to which the following are, for example, leaves, needles, stems, branches, flowers, fruiting bodies, fruits and seeds, and also roots, tubers, corms and rhizomes. Cereals, and vegetative, and generative seeds, such as cuttings, corms, rhizomes, tubers, shoots and seeds, also apply to parts of plants.

Among the plants that can be protected by the method in accordance with the invention, mention may be made of the main field crop plants, such as corn, soybeans, cotton, vgakkuya oilseeds, such as vgakkuya wig (eg canola), vgakkuhara gara, B ..) ipsea (for example, mustard) and Vgakkya sappay-g rice, wheat, sugar beets, sugarcane, oats, rye, barley, millet, triticale, flax, vine and various fruits and vegetables from various plant taxa, such as (for example, single-seeded fruit such as apples and pears, but also stone fruit such as apricots, cherries, almonds and peaches, berries such as strawberries), Kökümäe cr., 1id1apyasee cr., Be1i1asee cr., Apasagasasee cr., Radaseae cr., Mogasee cr. ., Laigasee cr., Mikasee cr. (for example, banana trees and plantations), KiSasee cr. (for example, coffee), ТНеасее кр., НегсиПсее кр., Кшасее кр. (e.g. lemons, oranges, and grapefruits); 8o1apasee cr. (e.g. tomatoes, potatoes, peppers, eggplants), Lhasae cr., Sotrokshae cr. (for example, lettuce, artichoke and chicory - including chicory root, chicory, or chicory in general) (for example, carrots, parsley, lettuce celery and root celery), SisigPaseae cr. (for example, a cucumber - including gherkin, table pumpkin, watermelon, bottle gourd and melon), LShasee cr. (for example, onions and leeks), Sgisghegae cr. (for example, white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, Beijing cabbage, kohlrabi, radishes, horseradish, watercress, Chinese cabbage), Editshokae cr. (for example, peanuts, peas, and beans - such as fried beans and fodder beans), S’NeporoShasee cr. (for example, fodder beets, leaf beets, spinach, beets), Mauluasae (for example, okra), Akragadasae (for example, asparagus); garden and forest crops; ornamental plants; as well as genetically modified homologues of these crops.

The processing method in accordance with the invention can be used in the treatment of genetically modified organisms (GMOs), for example plants or seeds. Genetically modified plants (or transgenic plants) are plants of which the heterologous gene is stably integrated into the genome. The expression heterologous gene essentially means a gene that is provided or assembled outside the plant and when introduced into the nucleus, the chloroplast or mitochondrial genome gives the transformed plant new or improved agronomic or other properties by expressing the protein or polypeptide of interest, or by down regulation or silencing of the other gene (s) that are present in the plant (using, for example, antisense technology, cosuppression technology or RNA interference - RNA -interference technology). The heterologous gene that is in the genome is also called the transgene. A transgene, which is determined by its specific location in the genome of a plant, is called a transformational or transgenic object.

Depending on the species or varieties of plants, their location and growth conditions (soil, climate, growing season, nutrition), processing in accordance with the invention can also lead to super-additive (synergistic) effects. Thus, it is possible, for example, to reduce consumption rates and / or expand the spectrum of action and / or increase the activity of active compounds and compositions that can be used in accordance with the invention, better plant growth, increased resistance to high or low temperatures, increased resistance to dryness, or to water, or to the salt content in the soil, increased flowering productivity, easier harvesting, faster ripening, higher crop sizes, larger fruits, more pain higher plant height, greener leaf color, earlier flowering, higher quality and / or higher nutritional value of crop products, higher concentration of sugar in the fruit, increased storage stability and / or processability of crop products that exceed the effects that were really to be expected.

At certain utilization rates, combinations of active substances in accordance with the invention may also have a strengthening effect in plants. Accordingly, they are also suitable for mobilizing the plant defense system against damage by undesirable microorganisms. This may, if appropriate, be one of the reasons for the increased activity of the combinations according to the invention, for example, against fungi. Substances that strengthen plants (stimulation of resistance) should be understood as meaning in this context substances or combinations of substances that can stimulate the protective system of plants in such a way that when subsequently inoculated with undesirable microorganisms, the treated plants show a significant degree of resistance to these microorganisms. In this case, it should be understood that undesirable microorganisms are phytopathogenic fungi, bacteria and viruses. Thus, the substances in accordance with the invention can be used to protect plants from damage by the above pathogens for a certain period of time after treatment. The period of time during which protection is carried out usually lasts from 1 to 30 days, preferably from 1 to 14 days, after treatment of plants with biologically active compounds.

A plant and plant cultivars that are preferred to be processed in accordance with the invention include all kinds of plants that have genetic material that provides particularly preferred, beneficial traits to these plants (or obtained by selection and / or biotechnological methods).

Plant and plant varieties of plants, which are also preferred to be processed in accordance with the invention, are resistant to one or more biotic stress effects, i.e. these plants show better protection against animals and microbial pests, such as against nematodes, insects, ticks, pathogenic fungi, bacteria, viruses and / or viroids.

Examples of nematode-resistant plants are described, for example, in US patent applications No. 11 / 765,491, 11 / 765,494, 10 / 926,819, 10 / 782,020, 12 / 032,479, 10 / 783,417, 10 / 782,096, 11 / 657,964, 12 / 192,904 11 / 396,808, 12 / 166,253, 12 / 166,239, 12 / 166,124, 12 / 166,209, 11 / 762,886, 12 / 364,335, 11 / 763,947, 12 / 252,453, 12 / 209,354, 12 / 491,396 and 12 / 497,221.

The plant and plant varieties of plants, which can also be processed in accordance with the invention, are those plants that are resistant to one or more abiotic stresses. Abiotic stress exposure conditions may include, for example, drought, exposure to cold temperature, heat exposure, osmotic stress exposure, floods, increased soil salinity, increased mineral effects, ozone exposure, high light exposure, limited availability of nutrient nitrogen, limited availability of nutrient phosphorus avoiding the shadow.

The plant and plant varieties of plants, which can also be processed in accordance with the invention, are those plants that are characterized by improved yield characteristics. Increased yields in these plants can be the result of, for example, improved plant physiology, growth and development, for example, water use efficiency, water retention efficiency, improved nitrogen use, increased carbon assimilation, improved photosynthesis, increased germination efficiency and accelerated maturation. Yields can also be influenced by improved plant architecture (under stress and non-stress conditions), including, but not limited to, early flowering, flowering control for hybrid seed productivity, sowing vitality, plant size, number and distance of internodes , root growth, seed size, fruit size, pod size,

- 21 027125 the number of pods or spikelets, the number of seeds per pod or spike, the mass of seeds, increased seed capacity, reduced seed dispersion, reduced divergence of the edges of the pod and resistance to lodging. Further signs of yield include seed composition, such as carbohydrate content, protein content, oil content and composition, nutritional value, reduced nutritional benefits, improved processability and better storage stability.

Plants that can be treated in accordance with the invention are hybrid plants that already express a characteristic of heterosis or hybrid strength, which usually results in higher yields, vitality, health and resistance to biotic and abiotic stress. Such plants are usually obtained by crossing the parent line with innate male sterility (female parenthood) with another parent line with innate male fertility (male parenthood). Hybrid seed, as a rule, gives a crop of male sterile plants and is sold to producers. Male sterile plants can sometimes be obtained (for example, in corn) by removing panicle inflorescences, i.e. by mechanically removing male genital organs (or male flowers), but more typically male sterility is the result of genetic determinants in the genome of a plant. In this case, and especially when the seeds are the desired product to yield from hybrid plants, it is usually useful to ensure that male fertility in hybrid plants is fully restored. This can be achieved by ensuring that male parents have appropriate fertility reducing genes that are capable of restoring male fertility in hybrid plants that contain the genetic determinants responsible for male sterility. Genetic determinants for male sterility can be located in the cytoplasm. Examples of cytoplasmic male sterility (CM8) have been described, for example, in Whackwort chrysalis. However, genetic determinants for male sterility can also be located in the nuclear genome. Male sterile plants can also be obtained using biotechnological plant methods, such as genetic engineering. A particularly useful method for producing plants with male sterility is described in \ UO 89/10396, in which, for example, ribonuclease, such as barnase, is selectively expressed in tapetum cells in stamens. Fertility can then be restored by expression of a ribonuclease inhibitor, such as barstar, in tapetum cells.

Plant and plant cultivars (obtained using biotechnological methods for plants, such as genetic engineering) that can be processed in accordance with the invention, are resistant to plant herbicides, i.e. the resulting plants are resistant to one or more of these herbicides. Such plants can be obtained either by genetic transformation, or by breeding plants containing a mutation in the transmission of such resistance to herbicides.

Herbicide-resistant plants are, for example, glyphosate-resistant plants, i.e. plants obtained resistant to the herbicide glyphosate or its salts. Plants can be obtained resistant to glyphosate using various methods. For example, glyphosate-resistant plants can be obtained by transforming plants with a gene encoding the enzyme 5-enolpiruvilshikimat-3-phosphate synthase (ΕΡδΡδ). Examples of such ΕΡδΡδ genes are the AgoA gene (CT7 mutant) of the 8a1tope11a1ur1ntipit bacteria (Sota1 e! A1., 1983, 8 <lepse. 221, 370-371), the CΡ4 gene of the bacterium Adgoobacter cr. (Waggu e! A1., 1992, Sigg. Toryuk ΡΠιηΙ ΡΠνκίο1. 7, 139-145), genes encoding petunia ΕΡδΡδ (δ1κ · ι1ι e! A1., 1986, 8aepse, 233, 478-481), tomato ΕΡδΡδ ( Oakkeg e! A1., 1988, I. Vu1. Sit. 263, 4280-4289), or кораδΡδ korakan (\ UO 01/66704). It can also be a mutated ΕΡδΡδ. Glyphosate resistant plants can also be obtained by expressing a gene that encodes the glyphosate oxidative reductase enzyme. Glyphosate resistant plants can also be obtained by expressing a gene that encodes the glyphosate acetyltransferase enzyme. Glyphosate resistant plants can also be obtained by breeding plants containing naturally occurring mutations of the genes mentioned above. Plants expressing ΕΡδΡδ genes that confer glyphosate resistance are described. Plants containing other genes that confer glyphosate resistance, for example decarboxylase genes, are described.

Other herbicide-resistant plants, for example, are plants that are made herbicide-resistant by inhibiting the enzyme glutamine synthase, such as bialafos, phosphinotricin or glufosinate. Such plants can be obtained by expressing a herbicide detoxification enzyme or a mutant glutamine synthase enzyme that is resistant to inhibition. One such effective detoxifying enzyme is an enzyme encoding a phosphinotricin acetyltransferase (such as a piece or part of a protein from a δΐ ^ ΐ кре с с кре piece). Plants expressing exogenous phosphinotricin acetyltransferase are described.

In addition, herbicide resistant plants are also plants that are obtained herbicide resistant by inhibiting the enzyme hydroxyphenylpyruvate dioxygenase (ΠΡΡΌ). Hydroxyphenylpyruvate dioxygenase ΒΡΡΩ is an enzyme that catalyzes a reaction in which parahydroxyphenylpyruvate (HPP) is converted to homogenisate. Plants resistant to

- 22 027125

ΗΡΡΌ inhibitors, can be transformed with a gene encoding a naturally occurring resistant ΗΡΡΌ enzyme, or a gene encoding a mutant or chimeric ΗΡΡΌ enzyme, as described in MO 96/38567, MO 99/24585 and MO 99/24586, MO 2009/144079, MO 2002/046387 or I8 6768044. Resistance to ΗΡΡΌ inhibitors can also be obtained by transforming plants with genes encoding certain enzymes, allowing the formation of homogenisate, despite the inhibition of the native ΗΡΡΌ enzyme using a ΗΡΡΟ inhibitor. Such plants and genes are described in MO 99/34008 and MO 02/36787. Plant resistance to ΗΡΡΌ inhibitors can also be improved by transforming plants with a gene encoding an enzyme that has prefenate dehydrogenase (ΡΌΗ) activity, in addition to a gene encoding an ΗΡΡΌ resistant enzyme. as described in MO 2004/024928. In addition, plants can be made more resistant to ΗΡΡΟ-inhibitory herbicides by adding a gene to their genome that encodes an enzyme capable of metabolizing or destroying ΗΡΡΌ inhibitors, such as the CΥΡ450 enzymes shown in MO 2007/103567 and MO 2008/150473.

Still further, herbicide resistant plants are plants that are obtained resistant to acetolactate synthase inhibitors (AE8). Known AE8 inhibitors include, for example, sulfonylurea, imidazolinone, triazolopyrimidines, pyrimidinyloxy (thio) benzoates and / or sulfonylaminocarbonyltriazolinone herbicides. Various mutations in the AE8 enzyme (also known as acetohydroxyacid synthase, AΗA8) are known to confer resistance to various herbicides and groups of herbicides, as described, for example, in Tgai1 apy MiGy (2002, Meey 8s1epse, 50: 700712). Described is the preparation of plants resistant to sulfonylurea and plants resistant to imidazolinone. Other imidazolinone-resistant plants are also described. Additionally, plants resistant to sulfonylurea and imidazolinone are also described.

Other plants resistant to imidazolinone and / or sulfonylurea can be obtained by induced mutagenesis, selection in cell cultures in the presence of a herbicide or mutational selection, as described, for example, for soybeans in US patent No. 5084082, for rice in MO 97/41218 for sugar beets in US patent No. 5773702 and MO 99/057965, for salad in US patent No. 5198599 or for sunflower in MO 01/065922.

Plant and plant varieties of plants (obtained by biotechnological methods for plants, such as genetic engineering), which can also be processed in accordance with the invention, are insect resistant transgenic plants, i.e. plants obtained resistant to damage by certain target insects. Such plants can be obtained by genetic transformation or by selection of plants containing a mutation that provides such resistance to insects.

An insect resistant transgenic plant, as used herein, includes any plant containing at least one transgene containing an encoding of a coding sequence:

1) an insecticidal crystalline protein from Vasic Chicpis or its insecticidal part, such as crystalline insecticidal proteins listed in Systoget e1 a1. (1998, Mugojuogo apy Mo1esi1ag Vu1oogu Keu1e№k, 62: 807-813), updated by Sistogö e1 a1. (2005) in the nomenclature of the toxin VasShik TNipplechk online on the website: 11ir: // \ γ \ γ \ γ.1 ^ Γeks ^. Kikke. \ .Asl.ιk / Shot / Ne ^ 1_С ^^ skto ^ e / Vι /) or their insecticidal parts, for example, proteins of the CGU protein classes: CGU1AB, CGU1Ac, CGU1B, CGU1C, CGUH, CGU1P, CGU2AB, CGU3Aa or CGU3BB, or their insecticidal parts (for example, EP 1999141 and MO 2007/107302), or such synthesized proteins genes, as, for example, described in US patent application No. 12/249016; or

2) a crystalline protein from VasShik Tnippleuk or part thereof, which is insecticidal in the presence of a second other crystalline protein from Vaschik Tnippleuk or part thereof, such as a binary toxin obtained from crystalline proteins Cg34 and Cg35 (My11besk e1 a1. 2001, No. 1. B1cbn1). 19: 668-72; 8cbper £ e1 a1. 2006, Arroye Epuyopt. Mugogue 71, 1765-1774), or a binary toxin derived from Cg1A or Cg1P proteins and Cg2Aa, or Cg2Ab, or Cg2Ae proteins (US Patent Application No. 12/214022 and EP 08010791.5); or

3) a hybrid insecticidal protein containing portions of various insecticidal crystalline proteins from Habschinoprotein such as a protein hybrid, 1) the above protein or protein hybrid 2) the above protein, for example CgUA protein. 105 obtained by corn objects MOY89034 (MO 2007/027777); or

4) a protein according to any one of paragraphs 1) -3) above, where some, especially from 1 to 10, amino acids have been replaced by another amino acid in order to obtain higher insecticidal activity to target species of insects and / or to expand the range of target insect species susceptible to influence and / or due to changes introduced into the coding DNA during cloning or transformation, such as the Cr3Bl1 protein in corn objects MOY863 or MOY88017 or Crg3A protein in MGO.604 in the corn object; or

5) an insecticidal secreted protein from VasShik Yshppschepik or VasShik segeik, or its insecticidal part, for example, plant insecticidal (νΙΡ) proteins listed on the site:

- 23,027,125

1Shr: // \ y \ y \ u.PGs5sk5i55S \ .as.ik / 11ots / No.P_Spsktogs / В1Л'1р.1ит1. for example, proteins from the U1P3La protein class;

or

6) a secreted protein from VasShik Shippcheypayk or VasShik segeik, which is insecticidal in the presence of a second secreted protein from VasShik Shippshcheyk or B. segeik, such as a binary toxin obtained from U1P1A and U1P2A proteins (AO 94/21795); or

7) a hybrid insecticidal protein containing portions of various secreted proteins from VasShik Yshppscheyk or VasShik segeik, such as a protein hybrid in paragraph 1) above or a protein hybrid in paragraph 2) above; or

8) a protein according to any one of paragraphs 5) -7) above, where some, especially from 1 to 10, amino acids have been replaced by another amino acid in order to obtain higher insecticidal activity to target insect species, and / or to expand the range target insect species susceptible to and / or due to changes introduced into the coding DNA during the process of cloning or transformation (the same coding for the insecticidal protein), such as the U1P3Aa protein in the cotton object COT102; or

9) a secreted protein from VasShik Shippcheypayk or VasShik segeik, which is insecticidal in the presence of a crystalline protein from VasShik T1shppd1epk1k, such as a binary toxin obtained from U1P3 and SGu1A or SGu1P (US patent application No. 61/126083 and 61/195019), or the binary toxin consists of the U1P3 protein and the Cg2Aa, or Cg2Ab, or Cg2Ac proteins (US patent application No. 12/214022 and EP 08010791.5).

10) the protein according to paragraph 9) above, where some, especially from 1 to 10, amino acids were replaced by another amino acid in order to obtain higher insecticidal activity to target insect species, and / or to expand the range of target insect species that can be influenced and / or due to changes introduced into the coding DNA during the process of cloning or transformation (at the same time still coding for the insecticidal protein).

Of course, an insect resistant transgenic plant, as used herein, also includes any plant containing a combination of genes encoding the proteins of any one of the above classes 1-10. In one embodiment, the insect resistant plant implementation contains more than one transgene encoding a protein according to any one of the above classes 1-10, in order to expand the range of target insect species that are exposed when using different proteins directed at different target types of insects, or delay the development of insect resistance to plants by using various insecticidal proteins to the same target insect species, but which have a different mechanism of action, such as binding to different receptors, binding sites in the insect.

An insect resistant transgenic plant, as used herein, further includes any plant containing at least one transgene containing a sequence produced by the expression of double-stranded RNA that, when absorbed by a pest inside a plant, inhibits the growth of this pest .

Plant and plant cultivars (obtained by biotechnological methods for plants, such as genetic engineering), which can also be processed in accordance with the invention, are resistant to abiotic stress. Such plants can be obtained by genetic transformation or by breeding plants containing a mutation that provides such resistance to stressful effects:

1) plants that contain a transgene capable of reducing the expression and / or activity of the poly (AER-ribose) polymerase (PAKR) gene in plant cells or plants;

2) plants that contain an amplifying transgene of resistance to stress, capable of reducing the expression and / or activity of PAX, which encodes the genes of plants or plant cells;

3) plants that contain a stress transducer enhancing transgene that encodes a plant-functional enzyme of the reutilization pathway for the synthesis of nicotinamide adenine dinucleotide, including nicotinamidase, nicotinate phosphoribosyl transferase, nicotinic acid nicotinamide transaminase, nicotinamide adenine dinotin nitrosulfonamide.

Plant and varietal plant crops (obtained by biotechnological methods for plants, such as genetic engineering), which can also be processed in accordance with the invention, show a changed quantity, quality and / or storage stability of the harvested crop product and / or altered properties of the particular ingredients of the harvested crop product, such as:

1) transgenic plants that synthesize modified starch, which in its physicochemical characteristics, in particular amylose content or amylose / amylopectin ratio, degree of branching, average chain length, side chain distribution, viscosity parameter, gelling strength, starch grain size and / or starch grain morphology, is altered compared to synthesized starch in plant cells or non-mutant type plants, in a way that is more suitable for nodule tny applications;

- 24,027,125

2) transgenic plants that do not synthesize starchy carbohydrate polymers or which do not synthesize starchy carbohydrate polymers with altered properties in comparison with non-mutant type plants without genetic modification. Examples are plants producing polyfructose, especially the inulin and levane type, plants producing alpha-1,4-glucans, plants producing alpha-1,6 branched alpha-1,4-glucans, plants producing alternate;

3) transgenic plants that produce hyaluronan;

4) transgenic plants or hybrid plants, such as onions, with characteristics such as highly soluble solids, low toughness (LB) and / or long-term storage (L8).

Plant and plant varieties of plants (which can be obtained by biotechnological methods for plants, such as genetic engineering), which can also be processed in accordance with the invention, are plants, such as cotton, with altered fiber characteristics. Such plants can be obtained by genetic transformation or by breeding plants that contain a mutation that propagates such an altered characteristic of the fiber, and include:

a) plants, such as cotton, containing an altered form of cellulose synthase genes;

b) plants, such as cotton plants, containing an altered form of r5 \ y2 or G5 \ y3 homologous nucleic acids; plants, such as cotton, with increased expression of sucrose phosphate synthase;

c) plants, such as cotton, with increased expression of sucrose; plants, such as cotton plants, in which the terms of plasmodesmatal gating based on cell fibers change, for example, by down-regulating fiber-selective β-1,3-glucanase;

ά) plants, such as cotton, having fibers with altered reactivity, for example, through expression of the Ν-acetylglucosamine transferase gene, including the genes for iodine synthase and chitin.

Plant and plant varieties of crops (which can be obtained by biotechnological methods for plants, such as genetic engineering), which can also be processed in accordance with the invention, are plants, such as oilseed rape or relatives with cabbage plants, with altered characteristics of the oil profile . Such plants can be obtained by genetic transformation or by selection of plants that contain a mutation that spreads such altered characteristics of the oil profile, and include:

a) plants, such as oilseed rape, producing an oil that has a high oleic acid content;

b) plants, such as oilseed rape, producing oil that has a low content of linolenic acid;

c) plants, such as oilseed rape, producing oil that has a low level of saturated fatty acids.

The plant and plant varieties of plants (which can be obtained by plant biotechnology methods, such as genetic engineering), which can also be processed in accordance with the invention, are plants, such as potatoes, which are virus resistant, for example against the potato virus Υ ( object δΥ230 and δΥ233 from Tespor1ap1, Agdeiyia), which are resistant to diseases, for example, against late blight of potato (for example, KB gene), which show a decrease in the sweet taste caused by cold (bearing Νΐ-Ιηΐιΐι, ΙΙΚ-ΙΝν gene), or which have a dwarf phenotype (A-20 oxidase gene).

Plant and plant varieties of plants (which can be obtained by biotechnological methods for plants, such as genetic engineering), which can also be processed in accordance with the invention, are plants, such as oilseed rape or relatives with cabbage plants, with altered characteristics of shedding seeds . Such plants can be obtained by genetic transformation or by breeding plants that contain a mutation that propagates such altered characteristics of seed shedding, and include plants such as oilseed rape with delayed or reduced seed shedding.

Particularly useful transgenic plants that can also be processed in accordance with the invention are plants containing transformation objects, or combinations of transformation objects that are subject to unregulated status applications, in the United States of America, to the Animal and Plant Health Inspection Service (Ashsha1 AID R1ai1 Neayy Presyop §egu1se (ARN18)) of the United States Department of Agriculture (υδΌΑ), or such requests are being made or are still pending. At any time, this information is easily accessible from ARN18 (4700 Kueg CoaD K | uygya1e, ΜΌ 20737, υδΑ), for example, on its website (IKByr: /2№№№.арЫ8.and8Ya.do/bg8/po1_ged. B1m1). As of the filing date of this application, applications for non-regulated status that were pending the ARNK or submitted by the ARNK were those listed in Table B, which contains the following information:

- 25 027125

Application: application identification number. Technical descriptions of the objects of transformation can be found in separate application documents, which can be obtained from

ARN18, for example on the website of ARN18, with reference to this application number. These descriptions are incorporated herein by reference.

Distribution of application: reference to a previous application for which an extension is requested.

Institution: the name of the organization that submits the application.

Regulated article: Related plant species.

Transgenic phenotype: an acquired characteristic feature of plants using the object of transformation.

Transformation object or line: the name of the object or objects (sometimes also referred to as a line or lines) for which an unregulated status is requested.

ARN18 documents: various documents published by ARN18 in relation to the application and which may be requested by ARN18.

Additional especially useful plants containing single transformation objects or combinations of transformation objects are listed, for example, in the databases of various national or regional regulatory bodies (see, for example, Lp: // dl1 and £ 0 ..) gs / dtr_go_8. a8px and bp: //segadts.ogd/1pyeh.pb? eu1Ysoye = & b811BKhSoye = & dTure = & AbgSoye = & a1Soye = & 81Soye = & so1BSoye = & asyop = dt_sgory_eya!

The compositions in accordance with the invention include: a) fluopyram, b) optionally one or more active ingredients selected from insecticides, fungicides, biological control agents, as described above, c) optionally, fertilizers or growth stimulants.

Fluopyram according to the invention can be applied directly, i.e. without the inclusion of additional components, and without being diluted. In general, its application to seeds in the form of an acceptable composition is desirable. Suitable preparations and methods for processing seed are known to a person skilled in the art and are described, for example, in the following documents: I8 4272417 A, I8 4245432 A, I8 4808430 A, I8 5876739 A, I8 2003/0176428 A1, No. 0 2002/080675 A1 No. 0 2002/028186 A2.

Combinations of biologically active compounds or compositions that can be used in accordance with the invention can be converted to conventional seed dressing preparations, such as solutions, emulsions, suspensions, powders, foams, clay suspensions or other seed coating materials, and also in ui drugs.

These preparations are prepared in a known manner by mixing active compounds or combinations of active compounds or compositions with conventional additives, such as, for example, conventional fillers and also solvents or diluents, colorants, wetting agents, dispersants, emulsifiers, antifoam agents, preservatives, secondary thickeners, binders , gibberellins and, and possibly also water.

Suitable colorants that may be present in seed dressing preparations according to the invention include all conventional colorants for such purposes. Pigments with moderate solubility in water and dyes that are soluble in water can be used. Examples that may be mentioned include dyes known as rhodamine B, C.1. pigment red 112 and C.1. red 1, soluble in organic solvents.

Suitable wetting agents that may be present in seed dressing preparations according to the invention include all wetting agents that are common in the formulation of active agrochemicals. Advantageously, it is possible to use alkylnaphthalene sulfonates, such as diisopropyl or diisobutylnaphthalene sulfonates.

Suitable dispersants and / or emulsifiers that may be present in seed dressing preparations according to the invention include all non-ionic, anionic and cationic dispersants that are common in the formulation of active agrochemicals. Advantageously, it is possible to use nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants. Particularly suitable non-ionic dispersants are ethylene oxide propylene oxide block polymers, alkyl phenol polyglycol ethers, and tristyryl phenol polyglycol ethers and their phosphated or sulfated derivatives. Particularly suitable anionic dispersants are lignosulfonates, polyacrylic salts and the condensation products of aryl sulfonate with formaldehyde.

Suitable defoamers that may be present in seed dressing preparations according to the invention include all foam suppressants that are acceptable in the formulation of active agrochemicals. Advantageously, it is possible to use silicone antifoam agents and magnesium stearate.

- 26,027,125

Suitable preservatives that may be present in seed dressing preparations according to the invention include all substances that can be used for such purposes in agrochemical compositions. As an example, mention may be made of dichlorophene and semi-formaldehyde benzyl alcohol.

Suitable secondary thickeners that may be present in seed dressing preparations according to the invention include all substances that can be used for such purposes in agrochemical compositions. Cellulose derivatives, acrylic acid derivatives, xanthan gum, modified clays, and highly dispersed silica are preferred.

Suitable binders that may be present in seed dressing preparations according to the invention include all conventional binders that can be used to seed seed. Advantageously, polyvinyl pyrrolidone, polyvinyl acetate, polyvinyl alcohol and tylose can be mentioned.

Seed dressing preparations that will be used in accordance with the invention can be used directly or after dilution with water before treating the seed with any of a wide variety of types. For example, concentrates or preparations obtained from it by dilution with water can be used to dress seed of grain, such as wheat, barley, rye, oats, triticale, as well as seeds of corn, rice, oilseed rape, peas, field beans, cotton, sunflower and beetroot or another planting seed of any of the most diverse species. Suitable seed dressing preparations according to the invention or their diluted preparations can also be used to seed seed of transgenic plants. In this context, synergistic effects may also occur when interacting with substances formed by expression.

Suitable mixing equipment for treating the seed with seed dressing preparations to be used in accordance with the invention, or with preparations obtained from them by adding water, includes all mixing equipment that can usually be used for dressing. A specific procedure of your choice when the dressing involves introducing the seed into the mixer, adding the specific desired amount of dressing to dress the seed, either as it is or pre-diluted with water, and mixing until the seed is evenly distributed over the seed to the material. Optionally, a drying operation follows.

The specific consumption of seed dressing preparations to be used in accordance with the invention can vary within a relatively wide range. It depends on the specific content of active compounds in the preparations and on the seed material. In general, the specific consumption of the combination of active compounds is from 0.001 to 200 g per 1 kg of seed, preferably from 0.01 to 15 g per 1 kg of seed.

The good fungicidal effect of the active compounds that will be used in accordance with the invention in the treatment of seed is shown using the following examples.

Examples of using

Test field for the treatment of Ruphornidae dhashtea studies (winter barley) / seed.

Compounds were used as a standard preparation for treating 8C seed compared to untreated control.

Infected seed and compounds were introduced in the desired amounts into a seed treatment container and shaken for 1-2 minutes to ensure uniform distribution of the compound on the seeds. The size of the plot on the field was 2x1 m (= 2 m ² ), three repetitions were used. 'Tillage, pre-sowing preparation of the hole, fertilization and application of plant protection products were carried out in accordance with good agricultural practice. The study was evaluated with BBH 69% of the average value of the effectiveness, which corresponds to what was in the control, while the effectiveness of 100% means that the disease was not observed.

About treatment of Rugeporida gash1pea research (winter barley) / seed

Active compound Structure Specific consumption of active compound in g ai / 100 kg of seed Efficiency in% Fluopyram G I 10 one hundred BUT 5 one hundred GU XX 2,5 99.6 at one 98.7

- 27 027125

1ngo microtest Rugepor Yoga dhashtea, Rugepor Yoga LShGherepiz, Rugepor Yoga 1.

The microtest was carried out in a liquid medium with potato dextrose broth (RIV) using microtiter plates.

The active compound is used as a technical active substance dissolved in methanol, and 8 concentrations are obtained. The resulting concentration range was 0; 0,0003; 0.001; 0.003; 0.01; 0.03; 0.1 and 0.3 μg ai / ml for RugeporIoga dgatttea and RugeporIoga 1gez, as well as 0; 0.03; 0.1; 0.3; one; 3; 10 and 30 μg ai / ml for RugeporIoga LShsGherepiz.

A suspension of mycelium RugeporIoga dgattea or a suspension of spores in the case of RLpisGerepis or P. 1egez was used for inoculation. After 5 days of incubation for RugeporIoga dgattea and R.1egez or 7 days of incubation for RugeporIoga lhcgherepis in the dark with shaking (10 Hz), the optical density in each well was determined photometrically at 620 nm. EC ₅₀ values were calculated according to extinction coefficients (EC ₅₀ is the central characteristic of the isolate and shows the concentration at which pathogen growth decreases by 50%).

Rugepor Yoga dgattea study / t wIGo

Active connection Structure EC50 (ppm) Fluopyram Ά / y 0.08

Claims (8)

1. The use of fluopyram of formula (I) or its Ν-oxide for the treatment of seed from damage by RugeporIoga species transmitted with seeds. 2. The use according to claim 1 for the treatment of seed from the defeat of RugeporIoga auepae, RugeporIoga dgattea, RugeporIoga 1gez, RugeporIoga zetetregya, RugeporIoga LShsGherepIz. 3. The use according to claim 1 or 2 for the treatment of seed from the defeat of RugeporIoga dgattea transmitted with seeds, RFIcIcherepis, transmitted with seeds, and R.1egez transmitted with seeds. 4. The use according to any one of claims 1 to 3 for the treatment of seed of barley from the defeat of RugeporIoga dgattea and RugeporIoga 1 transmitted by the seeds. 5. The use according to any one of claims 1 to 3 for the treatment of wheat seed from the defeat of RugeporIoga LShGherepIz transmitted by seeds. 6. The use according to any one of claims 1 to 5, in which the treatment is etching. 7. A method for controlling phytopathogenic fungi of RugeporIoga dgattea, transmitted with seeds, RFIcIsGherepIz, transmitted with seeds, and R.1egez, transmitted with seeds, characterized in that the seed is treated with fluopyram according to claim 1. 8. The seed treated with fluopyram according to claim 1 for protection against damage by phytopathogenic fungi.